Tissue-specific	O
regulation	O
of	O
the	O
rabbit	B-DNA
15-lipoxygenase	I-DNA
gene	I-DNA
in	O
erythroid	B-cell_type
cells	I-cell_type
by	O
a	O
transcriptional	B-DNA
silencer	I-DNA
.	O

The	O
15-lipoxygenase	B-DNA
(	I-DNA
lox	I-DNA
)	I-DNA
gene	I-DNA
is	O
expressed	O
in	O
a	O
tissue-specific	O
manner	O
,	O
predominantly	O
in	O
erythroid	B-cell_type
cells	I-cell_type
but	O
also	O
in	O
airway	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
and	O
eosinophils	B-cell_type
.	O

We	O
demonstrate	O
in	O
this	O
report	O
that	O
the	O
5	B-DNA
'	I-DNA
flanking	I-DNA
DNA	I-DNA
of	O
the	O
15-lox	B-DNA
gene	I-DNA
contains	O
sequences	O
which	O
down-regulate	O
its	O
activity	O
in	O
a	O
variety	O
of	O
non-erythroid	B-cell_line
cell	I-cell_line
lines	I-cell_line
but	O
not	O
in	O
two	O
erythroid	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

The	O
element	O
has	O
characteristics	O
of	O
a	O
transcriptional	B-DNA
'silencer	I-DNA
'	I-DNA
since	O
it	O
functions	O
in	O
both	O
orientations	O
.	O

The	O
main	O
activity	O
of	O
the	O
silencer	B-DNA
has	O
been	O
mapped	O
to	O
the	O
first	O
900	O
bp	O
of	O
5	B-DNA
'	I-DNA
flanking	I-DNA
DNA	I-DNA
,	O
which	O
contains	O
nine	O
binding	O
sites	O
for	O
a	O
nuclear	B-protein
factor	I-protein
present	O
in	O
non-	O
erythroid	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

These	O
binding	O
sites	O
have	O
similar	O
sequences	O
and	O
multiple	O
copies	O
of	O
the	O
binding	B-DNA
sites	I-DNA
confer	O
tissue-specific	O
down-regulation	O
when	O
attached	O
to	O
a	O
minimal	B-DNA
lox	I-DNA
promoter	I-DNA
fragment	I-DNA
.	O

The	O
5	B-DNA
'	I-DNA
flanking	I-DNA
DNA	I-DNA
also	O
contains	O
a	O
cluster	O
of	O
three	O
binding	B-DNA
sites	I-DNA
for	O
the	O
GATA	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

3664-3672	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
©	NULL
1995	NULL
Oxford	NULL
University	NULL
Press	NULL
Tissue-specific	NULL
regulation	NULL
of	NULL
the	NULL
rabbit	NULL
15-lipoxygenase	NULL
gene	NULL
in	NULL
erythroid	NULL
cells	NULL
by	NULL
a	NULL
transcriptional	NULL
silencer	NULL
Jim	NULL
O'Prey	NULL
and	NULL
Paul	NULL
R.	NULL
Harrison*	NULL
Beatson	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
Laboratories	NULL
,	NULL
Garscube	NULL
Estate	NULL
,	NULL
Switchback	NULL
Road	NULL
,	NULL
Bearsden	NULL
,	NULL
Glasgow	NULL
G61	NULL
1BD	NULL
,	NULL
UK	NULL
Received	NULL
July	NULL
3	NULL
,	NULL
1995	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
August	NULL
18	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
The	NULL
15-lipoxygenase	NULL
(	NULL
lox	NULL
)	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
,	NULL
predominantly	NULL
in	NULL
erythroid	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
airway	NULL
epithelial	NULL
cells	NULL
and	NULL
eosinophils	NULL
.	NULL

We	NULL
demonstrate	NULL
in	NULL
this	NULL
report	NULL
that	NULL
the	NULL
5	NULL
flanking	NULL
DNA	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
contains	NULL
sequences	NULL
which	NULL
down-regulate	NULL
its	NULL
activity	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
non-erythroid	NULL
cell	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
two	NULL
erythroid	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
element	NULL
has	NULL
characteristics	NULL
of	NULL
a	NULL
transcriptional	NULL
'silencer	NULL
'	NULL
since	NULL
it	NULL
functions	NULL
in	NULL
both	NULL
orientations	NULL
.	NULL

The	NULL
main	NULL
activity	NULL
of	NULL
the	NULL
silencer	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
the	NULL
first	NULL
900	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
DNA	NULL
,	NULL
which	NULL
contains	NULL
nine	NULL
binding	NULL
sites	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
present	NULL
in	NULL
non-erythroid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

These	NULL
binding	NULL
sites	NULL
have	NULL
similar	NULL
sequences	NULL
and	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
confer	NULL
tissue-specific	NULL
down-regulation	NULL
when	NULL
attached	NULL
to	NULL
a	NULL
minimal	NULL
lox	NULL
promoter	NULL
fragment	NULL
.	NULL

The	NULL
5	NULL
flanking	NULL
DNA	NULL
also	NULL
contains	NULL
a	NULL
cluster	NULL
of	NULL
three	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
GATA	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

INTRODUCTION	NULL
Studies	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
highly	NULL
expressed	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
globin	NULL
genes	NULL
,	NULL
both	NULL
by	NULL
our	NULL
own	NULL
group	NULL
and	NULL
others	NULL
,	NULL
have	NULL
defined	NULL
the	NULL
importance	NULL
of	NULL
cis-control	NULL
regions	NULL
which	NULL
function	NULL
due	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
members	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
particularly	NULL
GATA-1	NULL
)	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
ubiquitous	NULL
factors	NULL
(	NULL
1,2	NULL
,	NULL
reviewed	NULL
in	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
also	NULL
presented	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
glutathione	NULL
peroxidase	NULL
gene	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Evidence	NULL
has	NULL
also	NULL
accumulated	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
negative	NULL
control	NULL
of	NULL
transcription	NULL
of	NULL
genes	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
contexts	NULL
(	NULL
reviewed	NULL
in	NULL
6-11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
in	NULL
particular	NULL
,	NULL
there	NULL
have	NULL
been	NULL
various	NULL
reports	NULL
of	NULL
negative	NULL
regulation	NULL
of	NULL
globin	NULL
(	NULL
12-19	NULL
)	NULL
and	NULL
non-globin	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
histone	NULL
H5	NULL
gene	NULL
(	NULL
20,21	NULL
)	NULL
,	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
and	NULL
the	NULL
glycophorin	NULL
B	NULL
gene	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
mechanisms	NULL
of	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

GenBank	NULL
accession	NULL
nos	NULL
M33291	NULL
and	NULL
X90860	NULL
The	NULL
LOXs	NULL
are	NULL
a	NULL
family	NULL
of	NULL
enzymes	NULL
which	NULL
catalyse	NULL
the	NULL
dioxygena-tion	NULL
of	NULL
polyenoic	NULL
acids	NULL
or	NULL
their	NULL
derivatives	NULL
containing	NULL
at	NULL
least	NULL
one	NULL
1,4-cis	NULL
,	NULL
cis-pentadiene	NULL
system	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Different	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
leuko-cytes	NULL
,	NULL
platelets	NULL
and	NULL
endothelial	NULL
cells	NULL
contain	NULL
LOXs	NULL
of	NULL
different	NULL
specificities	NULL
according	NULL
to	NULL
the	NULL
hydroperoxide	NULL
products	NULL
produced	NULL
with	NULL
arachidonic	NULL
acid	NULL
(	NULL
5,8,11,14-all-cis-eicosatetraenoic	NULL
acid	NULL
)	NULL
as	NULL
sub-strate	NULL
.	NULL

Three	NULL
different	NULL
enzymes	NULL
have	NULL
been	NULL
extensively	NULL
characterised	NULL
:	NULL
the	NULL
5-	NULL
,	NULL
12-	NULL
and	NULL
15-LOXs	NULL
,	NULL
although	NULL
other	NULL
LOX	NULL
activities	NULL
(	NULL
such	NULL
as	NULL
8-specificity	NULL
)	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
.	NULL

The	NULL
15-LOX	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
reticulocytes	NULL
,	NULL
where	NULL
it	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
mitochon-drial	NULL
degradation	NULL
(	NULL
25	NULL
)	NULL
,	NULL
but	NULL
also	NULL
in	NULL
eosinophils	NULL
and	NULL
epithelial	NULL
cells	NULL
of	NULL
the	NULL
bronchial	NULL
airways	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
is	NULL
regulated	NULL
both	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
29	NULL
)	NULL
and	NULL
mRNA	NULL
translation	NULL
during	NULL
reticulocyte	NULL
maturation	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
previous	NULL
work	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
rabbit	NULL
15-/ox	NULL
gene	NULL
and	NULL
defined	NULL
its	NULL
exon/intron	NULL
structure	NULL
and	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
negative	NULL
control	NULL
mechanisms	NULL
in	NULL
the	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
contains	NULL
a	NULL
tissue-specific	NULL
transcriptional	NULL
silencer	NULL
which	NULL
seems	NULL
to	NULL
function	NULL
by	NULL
binding	NULL
of	NULL
a	NULL
novel	NULL
factor	NULL
present	NULL
in	NULL
non-expression	NULL
tissues	NULL
that	NULL
is	NULL
not	NULL
the	NULL
previously	NULL
described	NULL
negative	NULL
regulator	NULL
,	NULL
YY	NULL
1	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
The	NULL
methods	NULL
for	NULL
cell	NULL
culture	NULL
,	NULL
transient	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
,	NULL
preparation	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
and	NULL
generation	NULL
of	NULL
site-directed	NULL
mutations	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
have	NULL
all	NULL
recently	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
cell	NULL
culture	NULL
Adherent	NULL
mouse	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
(	NULL
F4-12B2	NULL
;	NULL
a	NULL
gift	NULL
from	NULL
W.	NULL
Ostertag	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
mouse	NULL
epithelial	NULL
cell	NULL
line	NULL
C5	NULL
(	NULL
32	NULL
)	NULL
,	NULL
STO	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
HepG2	NULL
human	NULL
liver	NULL
cells	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
rabbit	NULL
skin	NULL
fibroblast	NULL
line	NULL
Rab	NULL
9	NULL
,	NULL
and	NULL
the	NULL
rabbit	NULL
lung	NULL
fibroblast	NULL
cell	NULL
line	NULL
R9AB	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
European	NULL
Collection	NULL
of	NULL
Animal	NULL
Cell	NULL
Cultures	NULL
,	NULL
Porton	NULL
Down	NULL
,	NULL
UK	NULL
and	NULL
were	NULL
grown	NULL
in	NULL
a	NULL
modification	NULL
of	NULL
Eagle	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
with	NULL
double	NULL
concentrations	NULL
of	NULL
amino	NULL
acids	NULL
and	NULL
vitamins	NULL
,	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
serum	NULL
(	NULL
Tissue	NULL
Culture	NULL
Services	NULL
)	NULL
and	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
with	NULL
100	NULL
ug	NULL
streptomycin	NULL
and	NULL
37.5	NULL
ug	NULL
penicillin/ml	NULL
.	NULL

The	NULL
human	NULL
erythroid/megakaryocyte	NULL
K562	NULL
cell	NULL
line	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Plasmid	NULL
constructions	NULL
Plasmids	NULL
pCAT19	NULL
,	NULL
pCAT-40	NULL
,	NULL
pCAT-150	NULL
and	NULL
pHSVBGal	NULL
were	NULL
constructed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

pCAT-40	NULL
and	NULL
pCAT-150	NULL
contain	NULL
sequences	NULL
extending	NULL
from	NULL
-40	NULL
and	NULL
-150	NULL
to	NULL
+20	NULL
bp	NULL
(	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
(	NULL
CAT	NULL
)	NULL
and	NULL
transcriptional	NULL
termination	NULL
sequences	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
2	NULL
(	NULL
HSV-2	NULL
)	NULL
immediate-early	NULL
5	NULL
gene	NULL
(	NULL
IE-5	NULL
)	NULL
.	NULL

pCAT-2700	NULL
was	NULL
obtained	NULL
by	NULL
co-ligation	NULL
of	NULL
a	NULL
1000	NULL
bp	NULL
Sstl-Xbal	NULL
fragment	NULL
from	NULL
pCAT-150	NULL
(	NULL
containing	NULL
15-lox	NULL
sequences	NULL
from	NULL
-150	NULL
to	NULL
+20	NULL
bp	NULL
,	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
the	NULL
HSV-2	NULL
IE-5	NULL
transcriptional	NULL
termination	NULL
sequences	NULL
)	NULL
with	NULL
a	NULL
2550	NULL
bp	NULL
Kprl-Ssfl	NULL
fragment	NULL
of	NULL
the	NULL
15-lox	NULL
genomic	NULL
clone	NULL
(	NULL
containing	NULL
sequences	NULL
from	NULL
-2700	NULL
to	NULL
-150	NULL
bp	NULL
)	NULL
into	NULL
KpnI-Xbal	NULL
digested	NULL
pUC19	NULL
.	NULL

pCAT-315	NULL
contains	NULL
a	NULL
335	NULL
bp	NULL
Smal-BamHI	NULL
fragment	NULL
from	NULL
pCAT-2700	NULL
containing	NULL
15-lox	NULL
sequences	NULL
from	NULL
-315	NULL
to	NULL
+20	NULL
bp	NULL
inserted	NULL
into	NULL
pCAT19	NULL
.	NULL

pCAT-430	NULL
contains	NULL
7	NULL
5-lox	NULL
sequences	NULL
from	NULL
-430	NULL
to	NULL
+20	NULL
bp	NULL
and	NULL
was	NULL
obtained	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
700	NULL
bp	NULL
EcoRI	NULL
fragment	NULL
of	NULL
pCAT-2700	NULL
into	NULL
EcoRI	NULL
cut	NULL
pCAT19	NULL
.	NULL

pCAT-930	NULL
was	NULL
obtained	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
615	NULL
bp	NULL
Smal	NULL
fragment	NULL
from	NULL
pCAT-2700	NULL
containing	NULL
15-lox	NULL
sequences	NULL
between	NULL
-930	NULL
and	NULL
-315	NULL
bp	NULL
into	NULL
Smal	NULL
digested	NULL
pCAT-315	NULL
.	NULL

pCAT-1800	NULL
and	NULL
pCAT-2200	NULL
contain	NULL
I5-lox	NULL
sequences	NULL
from	NULL
-1800	NULL
and	NULL
-2200	NULL
to	NULL
+20	NULL
bp	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
the	NULL
isolation	NULL
of	NULL
a	NULL
KpnI-HindlIII	NULL
fragment	NULL
of	NULL
pCAT-2700	NULL
containing	NULL
15-/ox	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
partially	NULL
digested	NULL
by	NULL
Tagl	NULL
or	NULL
PstI	NULL
and	NULL
fragments	NULL
containing	NULL
1800	NULL
or	NULL
2200	NULL
bp	NULL
of	NULL
15-lox	NULL
sequence	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
were	NULL
isolated	NULL
and	NULL
cloned	NULL
into	NULL
pUC19	NULL
.	NULL

The	NULL
mini-gene	NULL
construct	NULL
was	NULL
obtained	NULL
by	NULL
the	NULL
cloning	NULL
of	NULL
a	NULL
4600	NULL
bp	NULL
partial	NULL
Xbal-HindIlI	NULL
fragment	NULL
from	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
into	NULL
Xbal-HindlIll	NULL
digested	NULL
pCAT-2700	NULL
.	NULL

pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
5	NULL
``	NULL
-	NULL
contains	NULL
a	NULL
780	NULL
bp	NULL
Sstl	NULL
fragment	NULL
from	NULL
-930	NULL
to	NULL
-150	NULL
bp	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
and	NULL
was	NULL
prepared	NULL
by	NULL
cloning	NULL
this	NULL
fragment	NULL
into	NULL
Ssfl	NULL
digested	NULL
pCAT-930	NULL
.	NULL

pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
3'+	NULL
and	NULL
pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
3'-	NULL
were	NULL
prepared	NULL
by	NULL
cloning	NULL
the	NULL
blunt-ended	NULL
780	NULL
bp	NULL
Sstl	NULL
fragment	NULL
in	NULL
both	NULL
orientations	NULL
into	NULL
blunt-ended	NULL
,	NULL
HindIII	NULL
digested	NULL
pCAT-1	NULL
50.	NULL
pCAT-150	NULL
(	NULL
2.55	NULL
)	NULL
5	NULL
``	NULL
-	NULL
contains	NULL
a	NULL
2550	NULL
bp	NULL
Sstl	NULL
fragment	NULL
of	NULL
15-lox	NULL
sequence	NULL
from	NULL
-2700	NULL
to	NULL
-1	NULL
50	NULL
bp	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
and	NULL
was	NULL
prepared	NULL
by	NULL
cloning	NULL
this	NULL
fragment	NULL
into	NULL
Ssff	NULL
digested	NULL
pCAT-2700	NULL
.	NULL

pCAT-150	NULL
(	NULL
2.55	NULL
)	NULL
3'+	NULL
and	NULL
pCAT-150	NULL
(	NULL
2.55	NULL
)	NULL
3'-	NULL
constructs	NULL
were	NULL
obtained	NULL
by	NULL
cloning	NULL
the	NULL
blunt-ended	NULL
2550	NULL
bp	NULL
Sstl	NULL
fragment	NULL
in	NULL
both	NULL
orientations	NULL
into	NULL
blunt-ended	NULL
HindIII	NULL
digested	NULL
pCAT-150	NULL
.	NULL

pCAT-150	NULL
(	NULL
Fp	NULL
4	NULL
)	NULL
4	NULL
and	NULL
pCAT-150	NULL
(	NULL
Fp	NULL
5	NULL
)	NULL
;	NULL
were	NULL
prepared	NULL
by	NULL
cloning	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
Fp	NULL
4	NULL
binding	NULL
site	NULL
(	NULL
oligonucleotide	NULL
Fp	NULL
4	NULL
)	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
Fp	NULL
5	NULL
binding	NULL
site	NULL
(	NULL
oligonucleotide	NULL
Fp	NULL
5	NULL
)	NULL
linked	NULL
head-to-tail	NULL
in	NULL
the	NULL
natural	NULL
orientation	NULL
into	NULL
the	NULL
blunt-ended	NULL
Ssfl	NULL
site	NULL
of	NULL
pCAT-150	NULL
.	NULL

Concatamers	NULL
were	NULL
prepared	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
containing	NULL
a	NULL
BspMI	NULL
restriction	NULL
site	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

pCAT-150	NULL
(	NULL
GS	NULL
)	NULL
and	NULL
pCAT-150	NULL
(	NULL
GL	NULL
)	NULL
constructs	NULL
contain	NULL
15-lox	NULL
sequences	NULL
from	NULL
-551	NULL
to	NULL
-736	NULL
bp	NULL
and	NULL
-551	NULL
to	NULL
-930	NULL
bp	NULL
,	NULL
respectively	NULL
,	NULL
prepared	NULL
by	NULL
PCR	NULL
(	NULL
using	NULL
primers	NULL
L-2	NULL
and	NULL
L-3	NULL
for	NULL
GS	NULL
and	NULL
primers	NULL
L-1	NULL
and	NULL
L-3	NULL
for	NULL
GL	NULL
)	NULL
and	NULL
cloned	NULL
into	NULL
Ssfl	NULL
digested	NULL
pCAT-150	NULL
.	NULL

pCAT-150	NULL
(	NULL
GS	NULL
)	NULL
contains	NULL
FP	NULL
8	NULL
and	NULL
pCAT-150	NULL
(	NULL
GL	NULL
)	NULL
contains	NULL
FPs	NULL
8-11	NULL
linked	NULL
to	NULL
the	NULL
minimal	NULL
150	NULL
bp	NULL
15-lox	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
3665	NULL
The	NULL
pGPY289/2.55lox	NULL
construct	NULL
contains	NULL
the	NULL
2.55	NULL
kb	NULL
KprnI-SstI	NULL
fragment	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
from	NULL
-2700	NULL
to	NULL
-150	NULL
bp	NULL
inserted	NULL
into	NULL
the	NULL
Sstl	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
289	NULL
bp	NULL
glutathione	NULL
peroxidase	NULL
(	NULL
GPX	NULL
)	NULL
promoter/CAT	NULL
construct	NULL
pGPY289	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
all	NULL
constructs	NULL
was	NULL
determined	NULL
by	NULL
restriction	NULL
enzyme	NULL
site	NULL
mapping	NULL
and	NULL
all	NULL
constructs	NULL
produced	NULL
by	NULL
PCR	NULL
were	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
PCR	NULL
primers	NULL
The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
all	NULL
sequences	NULL
are	NULL
written	NULL
5-3	NULL
``	NULL
)	NULL
:	NULL
Fp	NULL
3	NULL
(	NULL
NF-1	NULL
)	NULL
,	NULL
_	NULL
AGGCGGGGTTAGTTGGAGACGAGCCATCCA	NULL
;	NULL
Fp	NULL
4	NULL
,	NULL
ATGCGGGACACGGAGCCTGGGGCAGAACGG	NULL
:	NULL
;	NULL
Fp	NULL
5	NULL
,	NULL
ATGCGCACCGCGGGTTCTGGGGAATGCGGG	NULL
;	NULL
Fp	NULL
7	NULL
,	NULL
CCCTGCTGGGCGGACGCCCAGGGCAGTAAC	NULL
;	NULL
oligo	NULL
M	NULL
,	NULL
GAGGCGAGCTGGCTGGTTCTGGTGTCITGG	NULL
;	NULL
FpSM	NULL
,	NULL
ATGCGCACCGCGGGGCGCAGGGAATGCGGG	NULL
;	NULL
G-3	NULL
,	NULL
AAGGGTTATTATCATIATTATTACCAITTATC	NULL
ATTATTATTTTTTATCACCGGTC	NULL
;	NULL
G-3M	NULL
,	NULL
AAGGGTTATTAGTATTATTATTACCAITTAGT	NULL
ATTATTATTITTITAGTACCGGTC	NULL
;	NULL
YY1	NULL
,	NULL
GATCGTTITGCGACATTITITTGCGACAC	NULL
;	NULL
OCT-1	NULL
,	NULL
AATTGCATGCCTGCAGGTCGACTCIAGAGGA	NULL
TCCATGCAAATGGATCCCCGGGTACCGAGCTC	NULL
;	NULL
GATA	NULL
,	NULL
CCGGGCAACTGATAAGGATTCCCTG	NULL
;	NULL
L-1	NULL
,	NULL
CGGAGCTCCCGGGCCACAGCAGAGAGCTGG	NULL
;	NULL
L-2	NULL
,	NULL
CGGAGCTCCCCACTGTGCCACAGTGCTGAC	NULL
;	NULL
L-3	NULL
,	NULL
CGGAGCTCGGGTCCTGCAGCCCCCAGCACC	NULL
;	NULL
Isolation	NULL
of	NULL
stable	NULL
transfectants	NULL
Stable	NULL
transfectants	NULL
were	NULL
generated	NULL
by	NULL
transfecting	NULL
cells	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
test	NULL
plasmid	NULL
and	NULL
0.2	NULL
ug	NULL
of	NULL
HOMER	NULL
6	NULL
plasmid	NULL
containing	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Sixteen	NULL
hours	NULL
later	NULL
,	NULL
10	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
was	NULL
applied	NULL
.	NULL

Stable	NULL
transfectants	NULL
were	NULL
selected	NULL
by	NULL
treatment	NULL
with	NULL
geneticin	NULL
(	NULL
800	NULL
ug/ml	NULL
;	NULL
GIBCO-BRL	NULL
)	NULL
for	NULL
3	NULL
weeks	NULL
,	NULL
and	NULL
colonies	NULL
(	NULL
>	NULL
100	NULL
)	NULL
were	NULL
pooled	NULL
.	NULL

Transfectants	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
with	NULL
either	NULL
4	NULL
mM	NULL
N	NULL
,	NULL
N	NULL
-hexamethylenebisacetamide	NULL
(	NULL
HMBA	NULL
)	NULL
or	NULL
1.6	NULL
%	NULL
dimethylsulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
for	NULL
up	NULL
to	NULL
7	NULL
days	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
cis-control	NULL
regions	NULL
To	NULL
search	NULL
for	NULL
any	NULL
tissue-specific	NULL
cis-control	NULL
regions	NULL
within	NULL
the	NULL
15-lox	NULL
genomic	NULL
DNA	NULL
regions	NULL
available	NULL
,	NULL
a	NULL
'mini-gene	NULL
'	NULL
was	NULL
constructed	NULL
containing	NULL
a	NULL
fragment	NULL
of	NULL
5'-flanking	NULL
DNA	NULL
from	NULL
-2.7	NULL
kb	NULL
to	NULL
+20	NULL
bp	NULL
linked	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
4.6	NULL
kb	NULL
of	NULL
-flanking	NULL
15-lox	NULL
gene	NULL
DNA	NULL
from	NULL
+8	NULL
to	NULL
+1	NULL
2.6	NULL
kb	NULL
linked	NULL
3	NULL
``	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
constructs	NULL
containing	NULL
5°	NULL
flanking	NULL
DNA	NULL
from	NULL
-40	NULL
to	NULL
+20	NULL
bp	NULL
(	NULL
pC	NULL
AT-40	NULL
)	NULL
,	NULL
-1	NULL
50	NULL
to	NULL
+20	NULL
bp	NULL
(	NULL
pCAT-1	NULL
50	NULL
)	NULL
and	NULL
-2.7	NULL
kb	NULL
to	NULL
+20	NULL
bp	NULL
(	NULL
pCAT-2700	NULL
)	NULL
linked	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
were	NULL
also	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
transfected	NULL
into	NULL
mouse	NULL
erythroid	NULL
(	NULL
MEL	NULL
)	NULL
or	NULL
epithelial	NULL
(	NULL
C5	NULL
)	NULL
cells	NULL
and	NULL
the	NULL
CAT	NULL
activity	NULL
measured	NULL
48	NULL
h	NULL
later	NULL
and	NULL
standardised	NULL
against	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
co-transfected	NULL
-galactosidase	NULL
expression	NULL
construct	NULL
,	NULL
pHSVBGal	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
show	NULL
that	NULL
the	NULL
pCAT-40	NULL
had	NULL
virtually	NULL
no	NULL
promoter	NULL
activity	NULL
in	NULL
either	NULL
cell	NULL
line	NULL
,	NULL
whereas	NULL
pCAT-150	NULL
had	NULL
similar	NULL
levels	NULL
of	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
[	NULL
as	NULL
compared	NULL
with	NULL
a	NULL
109	NULL
bp	NULL
murine	NULL
thymidine	NULL
kinase	NULL
gene	NULL
promoter	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
]	NULL
.	NULL

Both	NULL
the	NULL
mini-gene	NULL
and	NULL
3666	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
A	NULL
.	NULL

Relative	NULL
CAT	NULL
Activity	NULL
.	NULL

20	NULL
A	NULL
.60	NULL
.8	NULL
1.0	NULL
1.2	NULL
1.4	NULL
1.6	NULL
1.8	NULL
2.0	NULL
L	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
L	NULL
1	NULL
1	NULL
L	NULL
pCAT-40	NULL
pCAT-150	NULL
pCAT-2700	NULL
Mini-gene	NULL
--	NULL
B	NULL
Relative	NULL
CAT	NULL
Activity	NULL
*	NULL
20	NULL
4	NULL
.6	NULL
8	NULL
1.0	NULL
1.2	NULL
1.4	NULL
1.6	NULL
1	NULL
1	NULL
1	NULL
L	NULL
L	NULL
1	NULL
1	NULL
L	NULL
STO	NULL
C5	NULL
R9	NULL
Rab9	NULL
)	NULL
K562	NULL
]	NULL
Figure	NULL
1	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
5	NULL
negative	NULL
cis-control	NULL
region	NULL
.	NULL

The	NULL
averages	NULL
of	NULL
at	NULL
least	NULL
four	NULL
transfection	NULL
experiments	NULL
are	NULL
given	NULL
,	NULL
with	NULL
the	NULL
standard	NULL
errors	NULL
shown	NULL
as	NULL
error	NULL
bars	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Promoter	NULL
activity	NULL
of	NULL
5'-flanking	NULL
regions	NULL
of	NULL
75-lox	NULL
gene	NULL
linked	NULL
to	NULL
CAT	NULL
gene	NULL
and	NULL
then	NULL
introduced	NULL
into	NULL
MEL	NULL
(	NULL
open	NULL
boxes	NULL
)	NULL
or	NULL
C5	NULL
epithelial	NULL
cells	NULL
(	NULL
shaded	NULL
boxes	NULL
)	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

pCAT-40	NULL
,	NULL
pCAT-150	NULL
and	NULL
pCAT-2700	NULL
contain	NULL
75-lox	NULL
gene	NULL
sequences	NULL
from	NULL
-40	NULL
to	NULL
+20	NULL
bp	NULL
,	NULL
~1	NULL
50	NULL
to	NULL
+20	NULL
bp	NULL
and	NULL
-2.7	NULL
kb	NULL
to	NULL
+20	NULL
bp	NULL
linked	NULL
upstream	NULL
of	NULL
the	NULL
promoter-less	NULL
CAT	NULL
gene	NULL
.	NULL

The	NULL
mini-gene	NULL
contains	NULL
the	NULL
4.5	NULL
kb	NULL
of	NULL
75-lox	NULL
gene	NULL
3'-flanking	NULL
DNA	NULL
inserted	NULL
3	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
pCAT-2700	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
produced	NULL
by	NULL
each	NULL
CAT	NULL
construct	NULL
is	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
pCAT-150	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
transfection	NULL
of	NULL
pCAT-2700	NULL
into	NULL
erythroid	NULL
(	NULL
MEL	NULL
and	NULL
K562	NULL
)	NULL
and	NULL
non-erythroid	NULL
(	NULL
STO	NULL
,	NULL
C5	NULL
,	NULL
R9AB	NULL
and	NULL
Rab9	NULL
)	NULL
cells	NULL
.	NULL

pCAT-2700	NULL
had	NULL
slightly	NULL
higher	NULL
activity	NULL
(	NULL
2-	NULL
and	NULL
1.6-fold	NULL
,	NULL
respectively	NULL
)	NULL
than	NULL
the	NULL
pCAT-150	NULL
in	NULL
MEL	NULL
cells	NULL
;	NULL
whereas	NULL
they	NULL
had	NULL
very	NULL
little	NULL
activity	NULL
in	NULL
C5	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
shows	NULL
that	NULL
the	NULL
genomic	NULL
DNA	NULL
sequences	NULL
surrounding	NULL
the	NULL
15-/ox	NULL
gene	NULL
suppress	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
C5	NULL
cells	NULL
but	NULL
not	NULL
MEL	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
regions	NULL
responsible	NULL
are	NULL
located	NULL
primarily	NULL
in	NULL
the	NULL
2.7	NULL
kb	NULL
of	NULL
5°	NULL
flanking	NULL
DNA	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
constructs	NULL
containing	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
as	NULL
a	NULL
reporter	NULL
;	NULL
however	NULL
attempts	NULL
to	NULL
analyse	NULL
CAT	NULL
and	NULL
growth	NULL
hormone	NULL
mRNA	NULL
levels	NULL
and	NULL
transcription	NULL
start	NULL
sites	NULL
by	NULL
S1	NULL
mapping	NULL
or	NULL
RNAse	NULL
protection	NULL
in	NULL
these	NULL
experiments	NULL
has	NULL
proven	NULL
to	NULL
be	NULL
impossible	NULL
due	NULL
to	NULL
the	NULL
instability	NULL
of	NULL
the	NULL
mRNA	NULL
,	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
promoter	NULL
activity	NULL
and	NULL
the	NULL
relatively	NULL
inefficient	NULL
transfection	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
our	NULL
transient	NULL
assays	NULL
.	NULL

Defining	NULL
the	NULL
tissue-specific	NULL
silencer	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
down-regulation	NULL
of	NULL
15-lox	NULL
promoter	NULL
activity	NULL
was	NULL
a	NULL
peculiarity	NULL
of	NULL
MEL	NULL
cells	NULL
,	NULL
the	NULL
pCAT-150	NULL
and	NULL
pCAT-2700	NULL
constructs	NULL
were	NULL
introduced	NULL
into	NULL
another	NULL
erythroid	NULL
cell	NULL
line	NULL
of	NULL
human	NULL
origin	NULL
(	NULL
K562	NULL
)	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
fibroblast	NULL
or	NULL
epithelial	NULL
cell	NULL
lines	NULL
of	NULL
mouse	NULL
,	NULL
human	NULL
or	NULL
rabbit	NULL
origin	NULL
(	NULL
CS5	NULL
epithelial	NULL
cells	NULL
,	NULL
the	NULL
STO	NULL
mouse	NULL
fibroblast	NULL
line	NULL
;	NULL
RAB	NULL
and	NULL
Rab9	NULL
rabbit	NULL
skin	NULL
and	NULL
lung	NULL
fibroblast-like	NULL
lines	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
show	NULL
that	NULL
the	NULL
pCAT-2700	NULL
construct	NULL
was	NULL
as	NULL
active	NULL
as	NULL
the	NULL
pCAT-150	NULL
construct	NULL
in	NULL
both	NULL
erythroid	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
it	NULL
had	NULL
very	NULL
low	NULL
activity	NULL
in	NULL
all	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
define	NULL
the	NULL
location	NULL
of	NULL
the	NULL
sequences	NULL
responsible	NULL
for	NULL
the	NULL
down-regulation	NULL
more	NULL
precisely	NULL
,	NULL
a	NULL
series	NULL
of	NULL
5¢	NULL
deletions	NULL
of	NULL
the	NULL
15-lox	NULL
DNA	NULL
in	NULL
pCAT-2700	NULL
were	NULL
constructed	NULL
and	NULL
tested	NULL
by	NULL
transfection	NULL
into	NULL
MEL	NULL
,	NULL
C5	NULL
and	NULL
Rab	NULL
9	NULL
cells	NULL
as	NULL
before	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
show	NULL
that	NULL
down	NULL
regulation	NULL
in	NULL
non-erythroid	NULL
cells	NULL
is	NULL
gradually	NULL
lost	NULL
as	NULL
the	NULL
5	NULL
``	NULL
flanking	NULL
DNA	NULL
is	NULL
progressively	NULL
deleted	NULL
from	NULL
-930	NULL
to	NULL
-315	NULL
bp	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
down-regulation	NULL
was	NULL
due	NULL
to	NULL
a	NULL
transcriptional	NULL
silencer	NULL
,	NULL
the	NULL
2.55	NULL
kb	NULL
fragment	NULL
from	NULL
-2.7	NULL
kb	NULL
to	NULL
-1	NULL
50	NULL
bp	NULL
was	NULL
cloned	NULL
in	NULL
either	NULL
the	NULL
natural	NULL
or	NULL
opposite	NULL
orientation	NULL
5	NULL
``	NULL
or	NULL
3	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
pCAT-150	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
promoter	NULL
activity	NULL
determined	NULL
after	NULL
transfection	NULL
into	NULL
MEL	NULL
or	NULL
C5	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
in	NULL
C5	NULL
cells	NULL
showed	NULL
that	NULL
CAT	NULL
activity	NULL
was	NULL
reduced	NULL
~20-fold	NULL
with	NULL
2.55	NULL
kb	NULL
fragment	NULL
placed	NULL
5	NULL
'	NULL
in	NULL
either	NULL
orientation	NULL
when	NULL
compared	NULL
with	NULL
pCAT-150	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lines	NULL
5	NULL
and	NULL
6	NULL
)	NULL
;	NULL
when	NULL
placed	NULL
3	NULL
'	NULL
,	NULL
the	NULL
negative	NULL
effect	NULL
was	NULL
lower	NULL
(	NULL
~2-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lines	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
but	NULL
still	NULL
significant	NULL
.	NULL

However	NULL
,	NULL
the	NULL
negative	NULL
effect	NULL
was	NULL
not	NULL
apparent	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lines	NULL
5-8	NULL
)	NULL
.	NULL

A	NULL
reduction	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
C5	NULL
cells	NULL
was	NULL
also	NULL
found	NULL
with	NULL
a	NULL
780	NULL
bp	NULL
fragment	NULL
from	NULL
-150	NULL
to	NULL
-930	NULL
bp	NULL
inserted	NULL
5°	NULL
in	NULL
either	NULL
orientation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lines	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
although	NULL
the	NULL
effect	NULL
(	NULL
5-6-fold	NULL
)	NULL
was	NULL
not	NULL
as	NULL
large	NULL
as	NULL
with	NULL
the	NULL
2550	NULL
bp	NULL
fragment	NULL
;	NULL
again	NULL
the	NULL
down-regulation	NULL
was	NULL
~2-fold	NULL
when	NULL
the	NULL
780	NULL
bp	NULL
fragment	NULL
was	NULL
placed	NULL
3	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lines	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
780	NULL
bp	NULL
fragment	NULL
of	NULL
the	NULL
1	NULL
5-lox	NULL
gene	NULL
contains	NULL
a	NULL
transcriptional	NULL
silencer	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
silencer	NULL
functions	NULL
in	NULL
a	NULL
promoter-specific	NULL
way	NULL
,	NULL
the	NULL
2.55	NULL
kb	NULL
5°	NULL
15-lox	NULL
gene	NULL
fragment	NULL
was	NULL
cloned	NULL
in	NULL
its	NULL
'natural	NULL
'	NULL
orientation	NULL
upstream	NULL
of	NULL
a	NULL
289	NULL
bp	NULL
minimal	NULL
promoter	NULL
from	NULL
the	NULL
glutathione	NULL
peroxidase	NULL
(	NULL
GPX	NULL
)	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
plasmid	NULL
pGPY289	NULL
(	NULL
5	NULL
)	NULL
to	NULL
give	NULL
pGPY289/2.55lox	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
minimal	NULL
289	NULL
bp	NULL
GPX	NULL
promoter	NULL
works	NULL
equally	NULL
well	NULL
in	NULL
both	NULL
MEL	NULL
and	NULL
C5	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Silencer	NULL
function	NULL
was	NULL
then	NULL
assessed	NULL
by	NULL
comparing	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
pGPY289/2.55lox	NULL
with	NULL
pGPY289	NULL
after	NULL
transfection	NULL
into	NULL
eythroid	NULL
cells	NULL
(	NULL
MEL	NULL
)	NULL
or	NULL
non-erythroid	NULL
cells	NULL
(	NULL
C5	NULL
or	NULL
Rab9	NULL
cells	NULL
)	NULL
;	NULL
the	NULL
results	NULL
were	NULL
then	NULL
compared	NULL
with	NULL
those	NULL
using	NULL
the	NULL
pCAT-2700	NULL
and	NULL
pCAT-150	NULL
15-lox	NULL
gene	NULL
constructs	NULL
transfected	NULL
in	NULL
parallel	NULL
experiments	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
show	NULL
that	NULL
the	NULL
15-lox	NULL
silencer	NULL
funtions	NULL
much	NULL
more	NULL
strongly	NULL
with	NULL
its	NULL
homologous	NULL
promoter	NULL
than	NULL
with	NULL
the	NULL
GPX	NULL
promoter	NULL
.	NULL

Nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
silencer	NULL
To	NULL
locate	NULL
any	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factors	NULL
in	NULL
the	NULL
silencer	NULL
region	NULL
,	NULL
the	NULL
first	NULL
930	NULL
bp	NULL
of	NULL
5'-flanking	NULL
DNA	NULL
was	NULL
subjected	NULL
to	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
using	NULL
the	NULL
eight	NULL
end-labelied	NULL
fragments	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
.	NULL

All	NULL
the	NULL
footprints	NULL
(	NULL
FPs	NULL
)	NULL
detected	NULL
are	NULL
displayed	NULL
against	NULL
the	NULL
15-lox	NULL
gene	NULL
sequence	NULL
in	NULL
Figure	NULL
4A	NULL
.	NULL

Eleven	NULL
reproducible	NULL
FPs	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
region	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
to	NULL
-930	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

3B-F	NULL
,	NULL
summarised	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

FPs	NULL
in	NULL
the	NULL
minimal	NULL
promoter	NULL
,	NULL
The	NULL
minimal	NULL
150	NULL
bp	NULL
promoter	NULL
fragment	NULL
used	NULL
in	NULL
the	NULL
functional	NULL
experiments	NULL
contains	NULL
three	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factors	NULL
present	NULL
in	NULL
both	NULL
erythroid	NULL
(	NULL
MEL	NULL
,	NULL
K562	NULL
)	NULL
and	NULL
non-erythroid	NULL
(	NULL
C5	NULL
,	NULL
HeLa	NULL
)	NULL
cell	NULL
types	NULL
(	NULL
FPs	NULL
1-3	NULL
,	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
:	NULL
these	NULL
correspond	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
,	NULL
AP-2	NULL
and	NULL
NF1	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
AP-2	NULL
site	NULL
appears	NULL
not	NULL
to	NULL
be	NULL
footprinted	NULL
in	NULL
Rab9	NULL
cells	NULL
or	NULL
in	NULL
HepG2	NULL
cells	NULL
which	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
express	NULL
AP-2	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
AP-2	NULL
site	NULL
probably	NULL
explains	NULL
why	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
pCAT-150	NULL
is	NULL
inducible	NULL
by	NULL
forskolin	NULL
and	NULL
TPA	NULL
after	NULL
transfection	NULL
into	NULL
MEL	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

1.	NULL
pCAT	NULL
-	NULL
2700	NULL
2.	NULL
pCAT	NULL
-	NULL
2200	NULL
3.	NULL
pCAT	NULL
-	NULL
1800	NULL
4.	NULL
pCAT	NULL
-	NULL
930	NULL
5.	NULL
pCAT	NULL
-	NULL
430	NULL
6.	NULL
pCAT	NULL
-315	NULL
B	NULL
.	NULL

1.	NULL
pCAT	NULL
-	NULL
150	NULL
(	NULL
0.78	NULL
)	NULL
5+	NULL
2.	NULL
pCAT	NULL
-	NULL
150	NULL
(	NULL
0.78	NULL
)	NULL
5'-3	NULL
.	NULL

pCAT	NULL
-	NULL
150	NULL
(	NULL
0.78	NULL
)	NULL
3+	NULL
4.	NULL
pCAT	NULL
-	NULL
150	NULL
(	NULL
0.78	NULL
)	NULL
3'-5	NULL
.	NULL

pCAT	NULL
-	NULL
150	NULL
(	NULL
2.55	NULL
)	NULL
5+	NULL
6.	NULL
pCAT	NULL
-	NULL
150	NULL
(	NULL
2.55	NULL
)	NULL
7.	NULL
pCAT	NULL
-150	NULL
(	NULL
2.55	NULL
)	NULL
3+	NULL
8.	NULL
pCAT	NULL
-	NULL
150	NULL
(	NULL
2.55	NULL
)	NULL
3'-	NULL
C.	NULL
1.	NULL
pGPy2s9	NULL
2.	NULL
pGPY289/2.55	NULL
lox	NULL
+	NULL
C	NULL
--	NULL
--	NULL
yFP	NULL
#	NULL
6	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
3667	NULL
Relative	NULL
CAT	NULL
activity	NULL
.	NULL

02	NULL
%	NULL
04	NULL
06	NULL
0	NULL
%	NULL
10	NULL
12	NULL
14	NULL
Relative	NULL
CAT	NULL
activity	NULL
.	NULL

02	NULL
04	NULL
06	NULL
0	NULL
%	NULL
10	NULL
12	NULL
14	NULL
Relative	NULL
CAT	NULL
activity	NULL
.	NULL

0.2	NULL
04	NULL
0.6	NULL
0.8	NULL
%	NULL
1.0	NULL
12	NULL
14	NULL
ferences	NULL
is	NULL
snore	NULL
Figure	NULL
2	NULL
.	NULL

Defining	NULL
the	NULL
negative	NULL
control	NULL
element	NULL
in	NULL
the	NULL
5'-flanking	NULL
DNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Deletion	NULL
mapping	NULL
.	NULL

Constructs	NULL
containing	NULL
different	NULL
5'-flanking	NULL
regions	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
were	NULL
transfected	NULL
into	NULL
MEL	NULL
cells	NULL
(	NULL
open	NULL
boxes	NULL
)	NULL
,	NULL
C5	NULL
cells	NULL
(	NULL
hatched	NULL
boxes	NULL
)	NULL
or	NULL
Rab9	NULL
cells	NULL
(	NULL
filled-in	NULL
boxes	NULL
)	NULL
and	NULL
the	NULL
CAT	NULL
activity	NULL
measured	NULL
48	NULL
h	NULL
later	NULL
.	NULL

The	NULL
constructs	NULL
pCAT-2700	NULL
,	NULL
pCAT-2200	NULL
,	NULL
pCAT-1800	NULL
,	NULL
pCAT-930	NULL
,	NULL
pCAT-430	NULL
,	NULL
pCAT-315	NULL
and	NULL
pCAT-150	NULL
contained	NULL
sequences	NULL
from	NULL
+20	NULL
to	NULL
-2700	NULL
bp	NULL
,	NULL
-2200	NULL
,	NULL
-1800	NULL
,	NULL
-930	NULL
,	NULL
-430	NULL
,	NULL
-315	NULL
and	NULL
-150	NULL
bp	NULL
,	NULL
respectively	NULL
,	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
with	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
pCAT-150	NULL
,	NULL
after	NULL
subtraction	NULL
of	NULL
the	NULL
slight	NULL
background	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
promoter-less	NULL
CAT	NULL
vector	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Evidence	NULL
that	NULL
the	NULL
5'-flanking	NULL
DNA	NULL
contains	NULL
a	NULL
transcriptional	NULL
silencer	NULL
.	NULL

The	NULL
780	NULL
bp	NULL
fragment	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
from-150	NULL
to	NULL
-930	NULL
bp	NULL
was	NULL
inserted	NULL
in	NULL
either	NULL
the	NULL
natural	NULL
(	NULL
+	NULL
)	NULL
or	NULL
reverse	NULL
(	NULL
-	NULL
)	NULL
orientation	NULL
5	NULL
'	NULL
to	NULL
the	NULL
150	NULL
bp	NULL
minimal	NULL
promoter	NULL
in	NULL
pCAT-150	NULL
to	NULL
give	NULL
pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
5+	NULL
or	NULL
pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
5	NULL
``	NULL
-	NULL
,	NULL
or	NULL
3	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
pCAT-150	NULL
to	NULL
give	NULL
pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
3'+	NULL
and	NULL
pCAT-150	NULL
(	NULL
0.78	NULL
)	NULL
3'-	NULL
,	NULL
respectively	NULL
.	NULL

Similar	NULL
constructs	NULL
were	NULL
made	NULL
by	NULL
inserting	NULL
the	NULL
2.55	NULL
kb	NULL
fragment	NULL
from	NULL
-150	NULL
bp	NULL
to	NULL
-2.7	NULL
kb	NULL
into	NULL
pCAT-150	NULL
instead	NULL
of	NULL
the	NULL
0.78	NULL
kb	NULL
fragment	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
MEL	NULL
,	NULL
C5	NULL
or	NULL
Rab9	NULL
cells	NULL
and	NULL
CAT	NULL
activities	NULL
expressed	NULL
relative	NULL
to	NULL
pCAT-150	NULL
.	NULL

The	NULL
key	NULL
to	NULL
the	NULL
cell	NULL
types	NULL
and	NULL
other	NULL
details	NULL
are	NULL
given	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Testing	NULL
the	NULL
silencer	NULL
with	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

The	NULL
2.55	NULL
kb	NULL
fragment	NULL
of	NULL
the	NULL
75-/ox	NULL
promoter	NULL
was	NULL
inserted	NULL
in	NULL
the	NULL
natural	NULL
orientation	NULL
5	NULL
'	NULL
to	NULL
a	NULL
minimal	NULL
promoter	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
cytosolic	NULL
glutathione	NULL
peroxidase	NULL
(	NULL
GPX	NULL
)	NULL
gene	NULL
(	NULL
containing	NULL
sequences	NULL
from	NULL
-289	NULL
to	NULL
+10	NULL
bp	NULL
,	NULL
hatched	NULL
box	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
[	NULL
pGPY289	NULL
(	NULL
5	NULL
)	NULL
]	NULL
to	NULL
give	NULL
pGPY289/2.5Slox+	NULL
.	NULL

pGPY289	NULL
and	NULL
pGPY/2.55lox	NULL
were	NULL
then	NULL
transiently	NULL
transfected	NULL
into	NULL
MEL	NULL
,	NULL
C5	NULL
or	NULL
Rab9	NULL
cells	NULL
[	NULL
see	NULL
(	NULL
A	NULL
)	NULL
for	NULL
key	NULL
to	NULL
cell	NULL
types	NULL
]	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
2.55	NULL
kb	NULL
fragment	NULL
on	NULL
the	NULL
GPX	NULL
promoter	NULL
can	NULL
be	NULL
compared	NULL
with	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
150	NULL
bp	NULL
lox	NULL
promoter	NULL
in	NULL
(	NULL
B	NULL
)	NULL
,	NULL
line	NULL
5	NULL
.	NULL

Non-erythroid-specific	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
silencer	NULL
fragment	NULL
.	NULL

FPs	NULL
4-7	NULL
and	NULL
10	NULL
(	NULL
Fig	NULL
.	NULL

3C-E	NULL
)	NULL
within	NULL
the	NULL
silencer	NULL
fragment	NULL
from	NULL
-150	NULL
to	NULL
-930	NULL
bp	NULL
are	NULL
only	NULL
found	NULL
with	NULL
non-erythroid	NULL
(	NULL
C5	NULL
)	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
FP4	NULL
,	NULL
5	NULL
,	NULL
6	NULL
and	NULL
7	NULL
regions	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
are	NULL
remarkably	NULL
similar	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
oligonucleotides	NULL
from	NULL
the	NULL
FP4	NULL
or	NULL
FP5	NULL
regions	NULL
compete	NULL
the	NULL
binding	NULL
to	NULL
FPs	NULL
7	NULL
and	NULL
10	NULL
strongly	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
and	NULL
F	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
FPs	NULL
4-7	NULL
and	NULL
10	NULL
all	NULL
bind	NULL
the	NULL
same	NULL
CS5	NULL
cell	NULL
factor	NULL
.	NULL

This	NULL
is	NULL
also	NULL
confirmed	NULL
by	NULL
EMSA	NULL
experiments	NULL
showing	NULL
that	NULL
at	NULL
least	NULL
two	NULL
specific	NULL
retarded	NULL
complexes	NULL
are	NULL
formed	NULL
with	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
FP4	NULL
region	NULL
with	NULL
three	NULL
different	NULL
non-erythroid	NULL
cell	NULL
extracts	NULL
(	NULL
C5	NULL
,	NULL
HeLa	NULL
and	NULL
Rab9	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
bands	NULL
1	NULL
and	NULL
2	NULL
)	NULL
;	NULL
these	NULL
FPs	NULL
are	NULL
competed	NULL
by	NULL
oligonucleotides	NULL
from	NULL
the	NULL
FP4	NULL
,	NULL
5	NULL
,	NULL
7	NULL
and	NULL
10	NULL
regions	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
version	NULL
of	NULL
FP5	NULL
(	NULL
FP5M	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
nor	NULL
by	NULL
oligonucleotides	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
NFI	NULL
or	NULL
Oct-1	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
another	NULL
oligonucleotide	NULL
[	NULL
M	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
]	NULL
from	NULL
the	NULL
15-lox	NULL
flanking	NULL
region	NULL
containing	NULL
sequences	NULL
similar	NULL
to	NULL
the	NULL
FP4-6	NULL
,	NULL
10	NULL
consensus	NULL
also	NULL
competes	NULL
with	NULL
FP5	NULL
in	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
although	NULL
this	NULL
region	NULL
and	NULL
another	NULL
region	NULL
,	NULL
N	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
showed	NULL
only	NULL
weak	NULL
binding	NULL
in	NULL
footprinting	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
complexes	NULL
in	NULL
some	NULL
tracks	NULL
appear	NULL
to	NULL
be	NULL
non-specific	NULL
since	NULL
they	NULL
are	NULL
not	NULL
competed	NULL
by	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabelled	NULL
FP4	NULL
oligonucleotide	NULL
in	NULL
Rab9	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
15-lox	NULL
silencer	NULL
elements	NULL
is	NULL
not	NULL
the	NULL
well	NULL
characterised	NULL
negative	NULL
regulator	NULL
known	NULL
as	NULL
YY	NULL
1	NULL
,	NULL
8	NULL
,	NULL
NF-E1	NULL
or	NULL
UCRBP	NULL
(	NULL
37-40	NULL
)	NULL
,	NULL
3668	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
A.	NULL
ano	NULL
eno	NULL
ano	NULL
200	NULL
B.	NULL
C.	NULL
Extract	NULL
|	NULL
|	NULL
|	NULL
|	NULL
a	NULL
S	NULL
P	NULL
R	NULL
S	NULL
S	NULL
B	NULL
|	NULL
<	NULL
4	NULL
i	NULL
m	NULL
m	NULL
ai	NULL
2	NULL
9	NULL
L	NULL
1	NULL
1	NULL
1	NULL
11	NULL
)	NULL
o	NULL
§	NULL
5	NULL
y	NULL
B	NULL
£	NULL
E	NULL
3	NULL
&	NULL
~	NULL
{	NULL
#	NULL
2	NULL
«	NULL
--	NULL
--	NULL
-~	NULL
z	NULL
a	NULL
10	NULL
I	NULL
3§	NULL
;	NULL
4	NULL
2	NULL
awe	NULL
``	NULL
*	NULL
7	NULL
«	NULL
{	NULL
--	NULL
--	NULL
--	NULL
s	NULL
8	NULL
<	NULL
--	NULL
-	NULL
-	NULL
&	NULL
dime	NULL
a	NULL
:	NULL
dime	NULL
--	NULL
-	NULL
103	NULL
jl	NULL
pad	NULL
2	NULL
%	NULL
we	NULL
|	NULL
*D3	NULL
°	NULL
Jne	NULL
p	NULL
Ti	NULL
stew	NULL
g	NULL
a	NULL
.	NULL

~~	NULL
...	NULL
.§	NULL
pel	NULL
o	NULL
6	NULL
``	NULL
``	NULL
fis	NULL
#	NULL
4	NULL
``	NULL
*	NULL
tes	NULL
«	NULL
o	NULL
we	NULL
w	NULL
»	NULL
-	NULL
CtP	NULL
Fp	NULL
2	NULL
Extract	NULL
:	NULL
-	NULL
‘	NULL
*	NULL
wien	NULL
Competitor	NULL
:	NULL
a	NULL
wee	NULL
'	NULL
as	NULL
Site	NULL
Aes	NULL
a	NULL
:	NULL
-	NULL
--	NULL
-	NULL
&	NULL
&	NULL
=	NULL
ame	NULL
a	NULL
«	NULL
ab	NULL
P	NULL
5	NULL
°_	NULL
&	NULL
Fp	NULL
7	NULL
Q	NULL
Te	NULL
Tt	NULL
'	NULL
2	NULL
~39	NULL
P	NULL
as	NULL
a	NULL
»	NULL
-	NULL
OB	NULL
§	NULL
|f	NULL
9	NULL
7	NULL
<	NULL
is	NULL
P	NULL
#	NULL
tow	NULL
.	NULL

mek	NULL
mi	NULL
-	NULL
ses	NULL
$	NULL
4	NULL
me	NULL
~	NULL
-	NULL
907	NULL
``	NULL
~	NULL
===	NULL
EE	NULL
l	NULL
Fp	NULL
11	NULL
Fp	NULL
10	NULL
l	NULL
Fp	NULL
9	NULL
Fp	NULL
10	NULL
Fp	NULL
11	NULL
2	NULL
4	NULL
a	NULL
iiaﬁé	NULL
t	NULL
i	NULL
Fp	NULL
8	NULL
wus	NULL
one	NULL
coa	NULL
ae	NULL
44-4	NULL
Figure	NULL
3	NULL
.	NULL

Footprinting	NULL
of	NULL
the	NULL
75-lox	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
to	NULL
-930	NULL
bp	NULL
.	NULL

The	NULL
fragments	NULL
shown	NULL
in	NULL
(	NULL
A	NULL
)	NULL
were	NULL
end-labelled	NULL
,	NULL
incubated	NULL
either	NULL
with	NULL
no	NULL
extract	NULL
(	NULL
0	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
types	NULL
stated	NULL
and	NULL
then	NULL
partially	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
before	NULL
electrophoresis	NULL
of	NULL
the	NULL
digestion	NULL
products	NULL
.	NULL

The	NULL
lanes	NULL
marked	NULL
A+G	NULL
show	NULL
the	NULL
results	NULL
of	NULL
chemical	NULL
cleavage	NULL
of	NULL
the	NULL
probes	NULL
at	NULL
adenosine	NULL
and	NULL
guanosine	NULL
residues	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Probe	NULL
1	NULL
;	NULL
(	NULL
C	NULL
)	NULL
probe	NULL
2	NULL
;	NULL
(	NULL
D	NULL
)	NULL
probe	NULL
3	NULL
;	NULL
(	NULL
E	NULL
)	NULL
probe	NULL
5	NULL
;	NULL
(	NULL
F	NULL
)	NULL
probe	NULL
6	NULL
.	NULL

The	NULL
other	NULL
probes	NULL
shown	NULL
in	NULL
(	NULL
A	NULL
)	NULL
were	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
location	NULL
of	NULL
the	NULL
footprints	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
competitors	NULL
used	NULL
in	NULL
(	NULL
D	NULL
)	NULL
and	NULL
(	NULL
E	NULL
)	NULL
were	NULL
oligonucleotides	NULL
from	NULL
the	NULL
FP4	NULL
or	NULL
FPS	NULL
regions	NULL
(	NULL
Fp4	NULL
and	NULL
Fp5S	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
nuclear	NULL
factor	NULL
NF	NULL
!	NULL

(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
.	NULL

CCCGGGCCAC	NULL
AGCAGAGAGC	NULL
TGGCCTOGAA	NULL
GAGGAGCAAC	NULL
COGGACAGAA	NULL
TCCGGCACCC	NULL
COTCTOUGAC	NULL
TAGAMCCCGG	NULL
TGTGTOGGCG	NULL
CCACTAGGTG	NULL
Teescaad	NULL
&	NULL
E_Secrercrar	NULL
cocetcrece	NULL
Torccace	NULL
B.	NULL
LOX	NULL
Fp	NULL
4	NULL
coc	NULL
e	NULL
|T	NULL
T	NULL
c	NULL
T	NULL
@	NULL
coc	NULL
LOX	NULL
Fp	NULL
5	NULL
G	NULL
e	NULL
e	NULL
|f	NULL
T	NULL
c	NULL
T	NULL
o	NULL
le	NULL
c	NULL
c	NULL
LOX	NULL
Fp	NULL
6	NULL
G	NULL
c	NULL
cC	NULL
|T	NULL
T	NULL
Cc	NULL
T	NULL
6	NULL
jc	NULL
e	NULL
T	NULL
LOX	NULL
Fp	NULL
7a	NULL
CoP	NULL
e	NULL
jT	NULL
T	NULL
Ac	NULL
T	NULL
@	NULL
jc	NULL
coc	NULL
LOX	NULL
Fp	NULL
7b	NULL
coc	NULL
CJT	NULL
G	NULL
c	NULL
Tt	NULL
@	NULL
|e	NULL
6	NULL
G	NULL
LOX	NULL
Fp	NULL
10	NULL
coc	NULL
c	NULL
|A	NULL
T	NULL
A	NULL
T	NULL
G	NULL
|G	NULL
6	NULL
A	NULL
LOX	NULL
oligo	NULL
N	NULL
G	NULL
6	NULL
T	NULL
|T	NULL
T	NULL
c	NULL
T	NULL
@	NULL
Jc	NULL
coc	NULL
LOX	NULL
oligo	NULL
M	NULL
T	NULL
G	NULL
6	NULL
|T	NULL
T	NULL
COT	NULL
@	NULL
[	NULL
6	NULL
T	NULL
<	NULL
consensus	NULL
Se	NULL
%	NULL
``	NULL
elt	NULL
t	NULL
c	NULL
®	NULL
s	NULL
)	NULL
%	NULL
e	NULL
bc	NULL
Ce	NULL
LOX	NULL
Fp	NULL
5M	NULL
G	NULL
e	NULL
c	NULL
6	NULL
c	NULL
G	NULL
A	NULL
6	NULL
G6	NULL
6	NULL
G	NULL
Figure	NULL
4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
75-/ox	NULL
-flanking	NULL
DNA	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
FPs	NULL
found	NULL
in	NULL
Figure	NULL
3	NULL
are	NULL
marked	NULL
:	NULL
underlined	NULL
(	NULL
solid	NULL
line	NULL
,	NULL
non-erythoid	NULL
cell-specific	NULL
;	NULL
dashed	NULL
line	NULL
,	NULL
ubiquitous	NULL
)	NULL
or	NULL
over-lined	NULL
(	NULL
dashed	NULL
line	NULL
,	NULL
erythroid-specific	NULL
)	NULL
with	NULL
the	NULL
conserved	NULL
binding	NULL
sites	NULL
for	NULL
non-erythroid	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
boxed	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
GATA-1	NULL
,	NULL
NFI	NULL
,	NULL
AP2	NULL
and	NULL
Sp1	NULL
are	NULL
also	NULL
marked	NULL
.	NULL

The	NULL
15-lox	NULL
gene	NULL
sequence	NULL
is	NULL
available	NULL
in	NULL
under	NULL
GenBank	NULL
accesssion	NULL
numbers	NULL
M33291	NULL
and	NULL
X90860	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
sequences	NULL
in	NULL
FPs	NULL
4-7	NULL
and	NULL
10	NULL
and	NULL
the	NULL
mutated	NULL
version	NULL
of	NULL
the	NULL
consensus	NULL
sequence	NULL
(	NULL
FP5M	NULL
)	NULL
used	NULL
in	NULL
Figure	NULL
5	NULL
.	NULL

Fp	NULL
5	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
3669	NULL
since	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
FP4	NULL
binding	NULL
site	NULL
does	NULL
not	NULL
compete	NULL
for	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
footprint	NULL
8	NULL
region	NULL
.	NULL

The	NULL
footprinting	NULL
experiment	NULL
shown	NULL
in	NULL
Figure	NULL
3E	NULL
shows	NULL
that	NULL
both	NULL
erythroid	NULL
and	NULL
non-erythroid	NULL
cells	NULL
contain	NULL
factors	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
in	NULL
vitro	NULL
.	NULL

Since	NULL
inspection	NULL
of	NULL
the	NULL
7	NULL
5-lox	NULL
gene	NULL
sequence	NULL
in	NULL
the	NULL
FP8	NULL
region	NULL
revealed	NULL
three	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
GATA-1	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
in	NULL
erythroid	NULL
and	NULL
non-erythroid	NULL
cells	NULL
was	NULL
investigated	NULL
further	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
clearly	NULL
show	NULL
the	NULL
same	NULL
series	NULL
of	NULL
multiple	NULL
retarded	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
bands	NULL
2-5	NULL
)	NULL
with	NULL
both	NULL
MEL	NULL
and	NULL
C5	NULL
nuclear	NULL
extracts	NULL
,	NULL
except	NULL
for	NULL
an	NULL
extra	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
band	NULL
1	NULL
)	NULL
found	NULL
only	NULL
with	NULL
MEL	NULL
nuclear	NULL
extracts	NULL
.	NULL

Competition	NULL
experiments	NULL
show	NULL
that	NULL
the	NULL
slowest	NULL
migrating	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
band	NULL
1	NULL
)	NULL
found	NULL
only	NULL
with	NULL
MEL	NULL
extracts	NULL
is	NULL
competed	NULL
with	NULL
a	NULL
GATA-1	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
mouse	NULL
-globin	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
other	NULL
retarded	NULL
complexes	NULL
are	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
an	NULL
FP8	NULL
oligonucleotide	NULL
mutated	NULL
in	NULL
each	NULL
of	NULL
the	NULL
three	NULL
GATA	NULL
sites	NULL
competes	NULL
out	NULL
bands	NULL
2-5	NULL
common	NULL
to	NULL
both	NULL
MEL	NULL
and	NULL
CS5	NULL
extracts	NULL
,	NULL
but	NULL
not	NULL
band	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
erythroid-specific	NULL
complex	NULL
is	NULL
also	NULL
preferentially	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
FPS	NULL
region	NULL
mutated	NULL
in	NULL
the	NULL
regions	NULL
between	NULL
the	NULL
three	NULL
GATA	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
both	NULL
erythroid	NULL
and	NULL
non-erythroid	NULL
cells	NULL
contain	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
sequences	NULL
in	NULL
the	NULL
FP8	NULL
region	NULL
between	NULL
the	NULL
GATA	NULL
sites	NULL
,	NULL
but	NULL
this	NULL
does	NULL
not	NULL
prevent	NULL
the	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
cells	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
,	NULL
at	NULL
least	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
these	NULL
non-tissue-specific	NULL
retarded	NULL
complexes	NULL
are	NULL
not	NULL
the	NULL
same	NULL
as	NULL
those	NULL
binding	NULL
to	NULL
FPs	NULL
4-7	NULL
and	NULL
10	NULL
since	NULL
a	NULL
FP4	NULL
olignucleotide	NULL
does	NULL
not	NULL
compete	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Other	NULL
binding	NULL
sites	NULL
.	NULL

Two	NULL
other	NULL
FPs	NULL
were	NULL
found	NULL
.	NULL

One	NULL
,	NULL
FP9	NULL
,	NULL
is	NULL
only	NULL
found	NULL
with	NULL
MEL	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3E	NULL
and	NULL
F	NULL
)	NULL
,	NULL
but	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
erythroid	NULL
factor	NULL
binding	NULL
is	NULL
unknown	NULL
:	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
bears	NULL
no	NULL
obvious	NULL
similarity	NULL
to	NULL
those	NULL
of	NULL
other	NULL
erythroid-specific	NULL
factors	NULL
.	NULL

The	NULL
other	NULL
,	NULL
FP11	NULL
,	NULL
is	NULL
found	NULL
with	NULL
both	NULL
MEL	NULL
and	NULL
C5	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3E	NULL
)	NULL
and	NULL
is	NULL
almost	NULL
certainly	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
NFI	NULL
,	NULL
Probe	NULL
:	NULL
Fp	NULL
4	NULL
a	NULL
Probe	NULL
:	NULL
Fp	NULL
5	NULL
&	NULL
Extract	NULL
:	NULL
HeLa	NULL
l	NULL
Ex	NULL
8	NULL
#	NULL
g	NULL
4	NULL
-	NULL
a	NULL
&	NULL
z	NULL
{	NULL
li	NULL
m	NULL
&	NULL
&	NULL
#	NULL
0	NULL
8	NULL
&	NULL
Competitor	NULL
:	NULL
-	NULL
-	NULL
$	NULL
$	NULL
#	NULL
s	NULL
amare	NULL
,	NULL
Probe	NULL
:	NULL
YY	NULL
f	NULL
s	NULL
&	NULL
Extract	NULL
MEL	NULL
¢s	NULL
ba	NULL
&	NULL
t	NULL
7	NULL
=	NULL
<	NULL
a	NULL
3	NULL
a	NULL
o.	NULL
a	NULL
.	NULL

<	NULL
a	NULL
.	NULL

_o	NULL
m_	NULL
&	NULL
_	NULL
i	NULL
R	NULL
gor	NULL
©	NULL
gov	NULL
a	NULL
E	NULL
Competitor	NULL
Logs	NULL
&	NULL
g	NULL
:	NULL
sos	NULL
$	NULL
&	NULL
#	NULL
,	NULL
*	NULL
4	NULL
O	NULL
Aal	NULL
Figure	NULL
5	NULL
.	NULL

EMSA	NULL
experiments	NULL
.	NULL

(	NULL
A	NULL
)	NULL
An	NULL
oligonucleotide	NULL
from	NULL
FP4	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
MEL	NULL
,	NULL
K562	NULL
,	NULL
C5	NULL
,	NULL
HeLa	NULL
and	NULL
Rab9	NULL
cells	NULL
and	NULL
then	NULL
analysed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
experiment	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
a	NULL
labelled	NULL
FPS	NULL
oligonucleotide	NULL
to	NULL
HeLa	NULL
cell	NULL
extracts	NULL
is	NULL
competed	NULL
by	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
oligonucleotides	NULL
from	NULL
the	NULL
FP4	NULL
,	NULL
FPS	NULL
,	NULL
FP7	NULL
,	NULL
FP10	NULL
or	NULL
oligo	NULL
M	NULL
regions	NULL
,	NULL
the	NULL
mutated	NULL
FPSM	NULL
oligonucleotide	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
or	NULL
oligonucleotides	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
nuclear	NULL
factors	NULL
NFI	NULL
or	NULL
Oct1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
labelled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
was	NULL
incubated	NULL
with	NULL
MEL	NULL
or	NULL
C5	NULL
nuclear	NULL
extracts	NULL
,	NULL
with	NULL
or	NULL
without	NULL
unlabelled	NULL
competitors	NULL
(	NULL
YY1	NULL
,	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
FP4	NULL
or	NULL
FpS	NULL
regions	NULL
,	NULL
or	NULL
a	NULL
GATA-1	NULL
binding	NULL
site	NULL
)	NULL
and	NULL
analysed	NULL
by	NULL
EMSA	NULL
.	NULL

3670	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
on	NULL
C	NULL
Figure	NULL
6	NULL
.	NULL

Analysis	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
FP8	NULL
region	NULL
.	NULL

A	NULL
labelled	NULL
oligonucleotide	NULL
from	NULL
the	NULL
FP8	NULL
region	NULL
was	NULL
incubated	NULL
with	NULL
MEL	NULL
or	NULL
C5	NULL
nuclear	NULL
extracts	NULL
with	NULL
or	NULL
without	NULL
the	NULL
unlabelled	NULL
competitors	NULL
indicated	NULL
,	NULL
and	NULL
analysed	NULL
by	NULL
EMSA	NULL
.	NULL

Key	NULL
to	NULL
competitors	NULL
used	NULL
:	NULL
G-3	NULL
,	NULL
FP8	NULL
oligonucleotide	NULL
;	NULL
G-3M	NULL
,	NULL
the	NULL
FP8	NULL
oligonucleotide	NULL
with	NULL
each	NULL
of	NULL
the	NULL
three	NULL
GATA	NULL
sites	NULL
mutated	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
;	NULL
GATA	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
GATA	NULL
site	NULL
from	NULL
the	NULL
mouse	NULL
gene	NULL
promoter	NULL
;	NULL
FP4	NULL
,	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
FP4	NULL
region	NULL
.	NULL

since	NULL
it	NULL
is	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3F	NULL
)	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
the	NULL
FP4	NULL
or	NULL
FP5	NULL
regions	NULL
alone	NULL
act	NULL
as	NULL
tissue-specific	NULL
negative	NULL
regulators	NULL
The	NULL
nuclear	NULL
protein	NULL
binding	NULL
experiments	NULL
described	NULL
above	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
to	NULL
the	NULL
FP4-7	NULL
and	NULL
10	NULL
regions	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
function	NULL
of	NULL
the	NULL
15-/ox	NULL
silencer	NULL
.	NULL

To	NULL
test	NULL
this	NULL
directly	NULL
,	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
FP4	NULL
sequence	NULL
,	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
FP5	NULL
sequence	NULL
,	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
15-lox	NULL
minimal	NULL
promoter	NULL
in	NULL
pCAT-150	NULL
and	NULL
their	NULL
effects	NULL
on	NULL
promoter	NULL
activity	NULL
assayed	NULL
after	NULL
transfection	NULL
into	NULL
MEL	NULL
or	NULL
C5	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
show	NULL
an	NULL
80	NULL
%	NULL
reduction	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
C5	NULL
and	NULL
Rab9	NULL
cells	NULL
,	NULL
whereas	NULL
only	NULL
a	NULL
10	NULL
%	NULL
reduction	NULL
is	NULL
evident	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
FP4	NULL
and	NULL
FP5	NULL
sequences	NULL
act	NULL
in	NULL
isolation	NULL
as	NULL
tissue-specific	NULL
negative	NULL
regulators	NULL
of	NULL
the	NULL
minimal	NULL
75-/ox	NULL
promoter	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
FPS	NULL
triplet	NULL
GATA	NULL
region	NULL
?	NULL

The	NULL
transient	NULL
transfection	NULL
experiments	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
show	NULL
that	NULL
the	NULL
930	NULL
bp	NULL
promoter	NULL
fragment	NULL
containing	NULL
the	NULL
GATA	NULL
sites	NULL
gives	NULL
only	NULL
a	NULL
small	NULL
increase	NULL
(	NULL
20	NULL
%	NULL
)	NULL
in	NULL
erythroid	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
minimal	NULL
150	NULL
bp	NULL
promoter	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
GATA	NULL
region	NULL
might	NULL
function	NULL
late	NULL
in	NULL
erythroid	NULL
differentiation	NULL
,	NULL
stable	NULL
transfectants	NULL
were	NULL
generated	NULL
containing	NULL
the	NULL
pCAT-150	NULL
,	NULL
pCAT-930	NULL
,	NULL
pCAT-2700	NULL
or	NULL
mini-gene	NULL
constructs	NULL
and	NULL
the	NULL
promoter	NULL
activity	NULL
measured	NULL
after	NULL
induction	NULL
of	NULL
differentiation	NULL
by	NULL
treatment	NULL
for	NULL
5	NULL
days	NULL
with	NULL
4	NULL
mM	NULL
HMBA	NULL
or	NULL
1.6	NULL
%	NULL
DMSO	NULL
.	NULL

To	NULL
control	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
position	NULL
of	NULL
integration	NULL
site	NULL
in	NULL
individual	NULL
transfectants	NULL
,	NULL
pools	NULL
of	NULL
at	NULL
least	NULL
100	NULL
transfectant	NULL
clones	NULL
were	NULL
analysed	NULL
.	NULL

However	NULL
,	NULL
promoter	NULL
activity	NULL
was	NULL
not	NULL
increased	NULL
for	NULL
any	NULL
of	NULL
the	NULL
constructs	NULL
during	NULL
MEL	NULL
cell	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
stable	NULL
MEL	NULL
transfectants	NULL
containing	NULL
the	NULL
FP8	NULL
or	NULL
FP8-11	NULL
regions	NULL
linked	NULL
directly	NULL
to	NULL
the	NULL
minimal	NULL
150	NULL
bp	NULL
lox	NULL
promoter	NULL
Relative	NULL
CAT	NULL
Activity	NULL
.	NULL

5	NULL
1.0	NULL
1.5	NULL
CAT	NULL
pCAT-150	NULL
communs	NULL
pCAT-930	NULL
pCAT-150	NULL
(	NULL
Fp	NULL
4	NULL
)	NULL
4	NULL
penenen	NULL
p	NULL
CAT-150	NULL
(	NULL
Fp	NULL
5	NULL
)	NULL
,	NULL
_.	NULL
as	NULL
Figure	NULL
7	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
tandem	NULL
copies	NULL
of	NULL
sequences	NULL
from	NULL
the	NULL
FP4	NULL
and	NULL
FPS	NULL
regions	NULL
linked	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
75-lox	NULL
promoter	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
FP4	NULL
region	NULL
,	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
FPS	NULL
region	NULL
,	NULL
were	NULL
inserted	NULL
upstram	NULL
of	NULL
the	NULL
150	NULL
bp	NULL
/5-lox	NULL
minimal	NULL
promoter	NULL
in	NULL
pCAT-150	NULL
,	NULL
transiently	NULL
transfected	NULL
into	NULL
MEL	NULL
,	NULL
C5	NULL
or	NULL
Rab9	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
determined	NULL
by	NULL
assays	NULL
of	NULL
CAT	NULL
activities	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
values	NULL
for	NULL
pCAT-1	NULL
50	NULL
.	NULL

Results	NULL
for	NULL
the	NULL
930	NULL
bp	NULL
promoter	NULL
fragment	NULL
,	NULL
containing	NULL
the	NULL
complete	NULL
silencer	NULL
(	NULL
pCAT-930	NULL
)	NULL
,	NULL
are	NULL
included	NULL
for	NULL
comparison	NULL
.	NULL

[	NULL
pCAT-150	NULL
(	NULL
GS	NULL
)	NULL
and	NULL
pCAT-150	NULL
(	NULL
GL	NULL
)	NULL
]	NULL
did	NULL
not	NULL
show	NULL
increased	NULL
promoter	NULL
activity	NULL
on	NULL
induction	NULL
of	NULL
differentiation	NULL
.	NULL

One	NULL
hypothesis	NULL
concerning	NULL
the	NULL
role	NULL
of	NULL
the	NULL
triplet	NULL
GATA	NULL
region	NULL
is	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
ubiquitous	NULL
factors	NULL
to	NULL
this	NULL
region	NULL
repress	NULL
the	NULL
15-lox	NULL
gene	NULL
but	NULL
GATA-1	NULL
releases	NULL
this	NULL
repression	NULL
.	NULL

This	NULL
seems	NULL
not	NULL
be	NULL
correct	NULL
since	NULL
a	NULL
CAT	NULL
construct	NULL
containing	NULL
the	NULL
FP8	NULL
region	NULL
linked	NULL
to	NULL
the	NULL
-150	NULL
bp	NULL
lox	NULL
promoter	NULL
[	NULL
pCAT-150	NULL
(	NULL
GS	NULL
)	NULL
]	NULL
does	NULL
not	NULL
show	NULL
down-regulated	NULL
expression	NULL
in	NULL
non-erythroid	NULL
C5	NULL
cells	NULL
in	NULL
which	NULL
GATA-1	NULL
is	NULL
not	NULL
expressed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
GATA-1	NULL
could	NULL
be	NULL
repressed	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
non-tissue-specific	NULL
factors	NULL
at	NULL
the	NULL
adjacent	NULL
sites	NULL
:	NULL
these	NULL
factors	NULL
might	NULL
only	NULL
disappear	NULL
from	NULL
erythroid	NULL
cells	NULL
at	NULL
late	NULL
stages	NULL
of	NULL
erythroid	NULL
maturation	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
non-tissue-specific	NULL
sites	NULL
decrease	NULL
during	NULL
MEL	NULL
differentiation	NULL
relative	NULL
to	NULL
the	NULL
GATA-1	NULL
level	NULL
,	NULL
EMSA	NULL
experiments	NULL
with	NULL
the	NULL
FP8	NULL
oligonucleotide	NULL
were	NULL
performed	NULL
using	NULL
extracts	NULL
from	NULL
MEL	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
erythroid	NULL
maturation	NULL
.	NULL

However	NULL
,	NULL
even	NULL
after	NULL
5	NULL
days	NULL
of	NULL
induction	NULL
with	NULL
1.6	NULL
%	NULL
DMSO	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
erythroid	NULL
and	NULL
ubiquitous	NULL
factors	NULL
remain	NULL
constant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
therefore	NULL
been	NULL
unable	NULL
to	NULL
obtain	NULL
evidence	NULL
that	NULL
the	NULL
GATA	NULL
and	NULL
FP9	NULL
regions	NULL
have	NULL
a	NULL
functional	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
.	NULL

DISCUSSION	NULL
The	NULL
major	NULL
conclusion	NULL
from	NULL
our	NULL
functional	NULL
studies	NULL
is	NULL
that	NULL
the	NULL
15-lox	NULL
gene	NULL
contains	NULL
multiple	NULL
copies	NULL
of	NULL
negative	NULL
elements	NULL
distributed	NULL
throughout	NULL
at	NULL
least	NULL
1	NULL
kb	NULL
of	NULL
5	NULL
``	NULL
flanking	NULL
DNA	NULL
that	NULL
only	NULL
function	NULL
in	NULL
non-erythroid	NULL
cells	NULL
and	NULL
collectively	NULL
have	NULL
the	NULL
properties	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
.	NULL

These	NULL
elements	NULL
bind	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
[	NULL
repressor	NULL
(	NULL
s	NULL
)	NULL
]	NULL
present	NULL
in	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
15-lox	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
(	NULL
various	NULL
fibroblast	NULL
and	NULL
epidermal	NULL
cell	NULL
lines	NULL
of	NULL
mouse	NULL
,	NULL
rabbit	NULL
and	NULL
human	NULL
origin	NULL
)	NULL
.	NULL

All	NULL
the	NULL
sites	NULL
appear	NULL
to	NULL
bind	NULL
the	NULL
same	NULL
factor	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
retarded	NULL
complexes	NULL
formed	NULL
with	NULL
each	NULL
of	NULL
the	NULL
sites	NULL
in	NULL
EMSA	NULL
experiments	NULL
migrate	NULL
at	NULL
the	NULL
same	NULL
position	NULL
and	NULL
are	NULL
competed	NULL
by	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
other	NULL
sites	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
7	NULL
5-/ox	NULL
gene	NULL
repressor	NULL
is	NULL
not	NULL
present	NULL
,	NULL
or	NULL
at	NULL
least	NULL
can	NULL
not	NULL
bind	NULL
,	NULL
in	NULL
cells	NULL
from	NULL
the	NULL
erythroid	NULL
lineage	NULL
in	NULL
which	NULL
the	NULL
1	NULL
5-LOX	NULL
is	NULL
expressed	NULL
(	NULL
mouse	NULL
and	NULL
human	NULL
erythroid	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

We	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
test	NULL
whether	NULL
these	NULL
silencer	NULL
elements	NULL
are	NULL
non-functional	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
in	NULL
which	NULL
the	NULL
15-LOX	NULL
is	NULL
expressed	NULL
(	NULL
airway	NULL
epithelial	NULL
cells	NULL
and	NULL
eosinophils	NULL
)	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
suitable	NULL
cell	NULL
lines	NULL
.	NULL

Also	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
possible	NULL
to	NULL
analyse	NULL
endogenous	NULL
15-LOX	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
since	NULL
the	NULL
rabbit	NULL
probes	NULL
do	NULL
not	NULL
cross-hybridize	NULL
with	NULL
mouse	NULL
and	NULL
human	NULL
genomic	NULL
DNA	NULL
or	NULL
mRNA	NULL
even	NULL
at	NULL
low	NULL
stringency	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Evidence	NULL
has	NULL
recently	NULL
accumulated	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
negative	NULL
control	NULL
of	NULL
transcription	NULL
of	NULL
genes	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
contexts	NULL
(	NULL
reviewed	NULL
in	NULL
6-11	NULL
)	NULL
.	NULL

In	NULL
general	NULL
terms	NULL
,	NULL
the	NULL
15-lox	NULL
silencer	NULL
elements	NULL
resemble	NULL
the	NULL
tissue-specific	NULL
silencers	NULL
involved	NULL
in	NULL
the	NULL
lineage-specific	NULL
regulation	NULL
of	NULL
the	NULL
immunoglobulin	NULL
x	NULL
(	NULL
41	NULL
)	NULL
and	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
42	NULL
)	NULL
genes	NULL
which	NULL
may	NULL
involve	NULL
Oct-2	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Silencers	NULL
have	NULL
also	NULL
recently	NULL
been	NULL
defined	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
y	NULL
and	NULL
&	NULL
g	NULL
globin	NULL
genes	NULL
(	NULL
13,15,44	NULL
)	NULL
and	NULL
the	NULL
well	NULL
characterised	NULL
zinc-finger	NULL
protein	NULL
known	NULL
as	NULL
YY1	NULL
,	NULL
8	NULL
,	NULL
NF-E1	NULL
or	NULL
UCRBP	NULL
(	NULL
37-40	NULL
)	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
their	NULL
activity	NULL
.	NULL

YY	NULL
1	NULL
is	NULL
of	NULL
considerable	NULL
interest	NULL
since	NULL
it	NULL
can	NULL
act	NULL
either	NULL
as	NULL
an	NULL
activator	NULL
(	NULL
40,45-47	NULL
)	NULL
or	NULL
as	NULL
a	NULL
repressor	NULL
(	NULL
15,37,38,40	NULL
)	NULL
of	NULL
transcription	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
context	NULL
and	NULL
the	NULL
other	NULL
nuclear	NULL
factors	NULL
with	NULL
which	NULL
it	NULL
interacts	NULL
(	NULL
reviewed	NULL
in	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
YY1	NULL
appears	NULL
not	NULL
to	NULL
be	NULL
the	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
1	NULL
5-lox	NULL
silencer	NULL
,	NULL
since	NULL
this	NULL
factor	NULL
is	NULL
tissue-specific	NULL
,	NULL
whereas	NULL
YY1	NULL
is	NULL
ubiquitous	NULL
,	NULL
and	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
75-lox	NULL
silencer	NULL
repressor	NULL
binding	NULL
site	NULL
does	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
to	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
in	NULL
EMSA	NULL
experiments	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
multiple	NULL
15-/ox	NULL
silencer	NULL
elements	NULL
remains	NULL
unknown	NULL
.	NULL

Positive	NULL
control	NULL
of	NULL
LOX	NULL
expression	NULL
?	NULL

Positive	NULL
control	NULL
of	NULL
erythroid-specific	NULL
expression	NULL
,	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
members	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
has	NULL
been	NULL
a	NULL
major	NULL
feature	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
globin	NULL
genes	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
genes	NULL
expressed	NULL
in	NULL
an	NULL
erythroid-specific	NULL
manner	NULL
(	NULL
1,2,3,5,18,23	NULL
)	NULL
.	NULL

The	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
1	NULL
5-lox	NULL
gene	NULL
contains	NULL
a	NULL
cluster	NULL
of	NULL
three	NULL
binding	NULL
sites	NULL
for	NULL
GATA	NULL
proteins	NULL
,	NULL
presumably	NULL
GATA-1	NULL
,	NULL
at	NULL
about	NULL
-750	NULL
bp	NULL
.	NULL

These	NULL
are	NULL
the	NULL
only	NULL
motifs	NULL
conforming	NULL
to	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
consensus	NULL
sequence	NULL
(	NULL
WGATAR	NULL
)	NULL
present	NULL
in	NULL
the	NULL
10	NULL
kb	NULL
of	NULL
15-lox	NULL
gene	NULL
sequence	NULL
presently	NULL
available	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
using	NULL
approaches	NULL
that	NULL
we	NULL
have	NULL
found	NULL
to	NULL
be	NULL
successful	NULL
in	NULL
identifying	NULL
positive	NULL
cis-control	NULL
regions	NULL
involved	NULL
in	NULL
the	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
other	NULL
genes	NULL
(	NULL
1,2,5	NULL
)	NULL
,	NULL
we	NULL
have	NULL
failed	NULL
to	NULL
detect	NULL
such	NULL
regions	NULL
by	NULL
functional	NULL
experiments	NULL
with	NULL
the	NULL
75-lox	NULL
genomic	NULL
fragments	NULL
available	NULL
,	NULL
which	NULL
contain	NULL
2.7	NULL
and	NULL
4.6	NULL
kb	NULL
of	NULL
5¢	NULL
and	NULL
3	NULL
'	NULL
flanking	NULL
DNA	NULL
,	NULL
respectively	NULL
.	NULL

None	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
containing	NULL
any	NULL
or	NULL
all	NULL
of	NULL
these	NULL
15-lox	NULL
gene	NULL
regions	NULL
,	NULL
including	NULL
the	NULL
'mini-gene	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
have	NULL
much	NULL
greater	NULL
promoter	NULL
activity	NULL
than	NULL
the	NULL
minimal	NULL
150	NULL
bp	NULL
15-lox	NULL
promoter	NULL
when	NULL
introduced	NULL
into	NULL
erythroid	NULL
cells	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
(	NULL
a	NULL
maximum	NULL
of	NULL
2-fold	NULL
for	NULL
the	NULL
mini-gene	NULL
construct	NULL
)	NULL
;	NULL
nor	NULL
do	NULL
the	NULL
constructs	NULL
function	NULL
more	NULL
efficiently	NULL
when	NULL
stable	NULL
erythroid	NULL
cell	NULL
transfectants	NULL
are	NULL
induced	NULL
to	NULL
differentiate	NULL
.	NULL

Introns	NULL
4	NULL
and	NULL
7	NULL
contain	NULL
multiple	NULL
copies	NULL
of	NULL
sequences	NULL
resembling	NULL
core	NULL
enhancer	NULL
motifs	NULL
(	NULL
G/TTGGA/TA/TA/TG	NULL
)	NULL
and	NULL
the	NULL
GGTGG	NULL
motif	NULL
found	NULL
in	NULL
many	NULL
erythroid	NULL
genes	NULL
[	NULL
located	NULL
at	NULL
nucleotides	NULL
2531-2560	NULL
and	NULL
4006-4438	NULL
(	NULL
31	NULL
)	NULL
]	NULL
:	NULL
however	NULL
,	NULL
these	NULL
do	NULL
not	NULL
have	NULL
enhancer	NULL
function	NULL
when	NULL
tested	NULL
by	NULL
transfection	NULL
experiments	NULL
in	NULL
either	NULL
erythroid	NULL
or	NULL
non-erythroid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
suspect	NULL
that	NULL
the	NULL
reason	NULL
why	NULL
the	NULL
GATA	NULL
sites	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
confer	NULL
erythroid-specific	NULL
transcription	NULL
in	NULL
these	NULL
experiments	NULL
is	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
region	NULL
between	NULL
the	NULL
GATA	NULL
sites	NULL
also	NULL
binds	NULL
other	NULL
,	NULL
ubiquitous	NULL
,	NULL
nuclear	NULL
proteins	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
these	NULL
proteins	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
3671	NULL
repress	NULL
the	NULL
1	NULL
5-lox	NULL
gene	NULL
in	NULL
non-expression	NULL
tissues	NULL
and	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
GATA-1	NULL
releases	NULL
this	NULL
repression	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

However	NULL
the	NULL
FP8	NULL
region	NULL
does	NULL
not	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
C5	NULL
cells	NULL
when	NULL
linked	NULL
to	NULL
the	NULL
minimal	NULL
150	NULL
bp	NULL
I5-/lox	NULL
gene	NULL
promoter	NULL
An	NULL
alternative	NULL
hypothesis	NULL
is	NULL
that	NULL
the	NULL
ubiquitous	NULL
factors	NULL
prevent	NULL
activation	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
by	NULL
GATA-1	NULL
and	NULL
that	NULL
15-lox	NULL
gene	NULL
transcription	NULL
requires	NULL
loss	NULL
of	NULL
these	NULL
factors	NULL
during	NULL
erythroid	NULL
cell	NULL
maturation	NULL
.	NULL

However	NULL
,	NULL
our	NULL
evidence	NULL
shows	NULL
that	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
role	NULL
of	NULL
the	NULL
FPS	NULL
region	NULL
in	NULL
15-lox	NULL
gene	NULL
expression	NULL
remains	NULL
unclear	NULL
.	NULL

The	NULL
sequence	NULL
to	NULL
which	NULL
the	NULL
ubiquitous	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bind	NULL
adjacent	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
is	NULL
very	NULL
AT-rich	NULL
and	NULL
remarkably	NULL
similar	NULL
to	NULL
an	NULL
AT-rich	NULL
region	NULL
at	NULL
about	NULL
-550	NULL
bp	NULL
in	NULL
the	NULL
human	NULL
f	NULL
}	NULL
-globin	NULL
gene	NULL
promoter	NULL
:	NULL
this	NULL
region	NULL
is	NULL
of	NULL
functional	NULL
importance	NULL
since	NULL
sequence	NULL
variations	NULL
affecting	NULL
binding	NULL
of	NULL
a	NULL
putative	NULL
repressor	NULL
protein	NULL
to	NULL
this	NULL
region	NULL
of	NULL
the	NULL
-globin	NULL
sickle	NULL
allele	NULL
(	NULL
(	NULL
®	NULL
)	NULL
also	NULL
affect	NULL
expression	NULL
of	NULL
the	NULL
[	NULL
3	NULL
allele	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
(	NULL
12,14	NULL
)	NULL
.	NULL

In	NULL
some	NULL
respects	NULL
,	NULL
this	NULL
region	NULL
containing	NULL
GATA	NULL
and	NULL
other	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
has	NULL
also	NULL
very	NULL
similar	NULL
characteristics	NULL
to	NULL
a	NULL
region	NULL
at	NULL
about	NULL
-75	NULL
bp	NULL
in	NULL
the	NULL
human	NULL
glycophorin	NULL
B	NULL
promoter	NULL
where	NULL
GATA	NULL
binding	NULL
displaces	NULL
binding	NULL
of	NULL
a	NULL
repressor	NULL
to	NULL
an	NULL
adjacent	NULL
site	NULL
and	NULL
allows	NULL
transcription	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
glycophorin	NULL
gene	NULL
repressor	NULL
binding	NULL
site	NULL
has	NULL
no	NULL
obvious	NULL
similarity	NULL
with	NULL
the	NULL
lox	NULL
gene	NULL
binding	NULL
site	NULL
and	NULL
does	NULL
not	NULL
compete	NULL
in	NULL
EMSA	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
mechanism	NULL
of	NULL
repressors	NULL
binding	NULL
to	NULL
sites	NULL
overlapping	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
occur	NULL
with	NULL
the	NULL
chicken	NULL
lysozyme	NULL
gene	NULL
(	NULL
48	NULL
)	NULL
and	NULL
the	NULL
rat	NULL
platelet	NULL
4	NULL
gene	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
summarise	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
repressor	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
15-lox	NULL
gene	NULL
silencer	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
preventing	NULL
15-lox	NULL
gene	NULL
expression	NULL
in	NULL
inappropriate	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
factor	NULL
is	NULL
not	NULL
present	NULL
,	NULL
or	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
multiple	NULL
silencer	NULL
elements	NULL
in	NULL
erythroid	NULL
cells	NULL
for	NULL
some	NULL
reason	NULL
,	NULL
perhaps	NULL
because	NULL
it	NULL
is	NULL
complexed	NULL
with	NULL
an	NULL
erythroid-specific	NULL
factor	NULL
such	NULL
as	NULL
GATA-1	NULL
or	NULL
SCL/Tal	NULL
.	NULL

Other	NULL
factors	NULL
present	NULL
in	NULL
both	NULL
erythroid	NULL
and	NULL
non-erythroid	NULL
cells	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
preventing	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
GATA-1	NULL
,	NULL
possibly	NULL
by	NULL
binding	NULL
at	NULL
adjacent	NULL
sites	NULL
.	NULL

ACKNOWLEDGEMENT	NULL
This	NULL
work	NULL
has	NULL
been	NULL
supported	NULL
by	NULL
the	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
.	NULL

REFERENCES	NULL
1	NULL
-	NULL
Frampton	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Walker	NULL
,	NULL
M.	NULL
Plumb	NULL
and	NULL
PR	NULL
.	NULL

Harrison	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2838-2842	NULL
.	NULL

2	NULL
Plumb	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
H.	NULL
Frampton	NULL
,	NULL
H.	NULL
Wainwright	NULL
,	NULL
M.	NULL
Walker	NULL
,	NULL
K.	NULL
MacLeod	NULL
,	NULL
G.	NULL
Goodwin	NULL
and	NULL
P.	NULL
Harrison	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
73-92	NULL
.	NULL

Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
665-672	NULL
.	NULL

Raich	NULL
,	NULL
N.	NULL
and	NULL
P.-H.	NULL
Romeo	NULL
(	NULL
1993	NULL
)	NULL
Stem	NULL
Cells	NULL
11	NULL
,	NULL
95-104	NULL
.	NULL

O'Prey	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Ramsay	NULL
,	NULL
I	NULL
.	NULL

Chambers	NULL
and	NULL
PR	NULL
.	NULL

Harrison	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
6290-6303	NULL
.	NULL

6	NULL
Hahn	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Current	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
152-154	NULL
.	NULL

7	NULL
Harmison	NULL
PR	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
In	NULL
T.M	NULL
.	NULL

Dexter	NULL
,	NULL
J.M	NULL
.	NULL

Garland	NULL
and	NULL
N.G	NULL
.	NULL

Testa	NULL
(	NULL
eds	NULL
)	NULL
,	NULL
Colony	NULL
Stimulating	NULL
Factors	NULL
,	NULL
Immunology	NULL
Series	NULL
,	NULL
vol	NULL
.	NULL

49	NULL
.	NULL

M.	NULL
Dekker	NULL
,	NULL
New	NULL
York	NULL
.	NULL

chapter	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

411-464	NULL
.	NULL

8	NULL
-	NULL
Jackson	NULL
,	NULL
ME	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
100	NULL
,	NULL
1-7	NULL
.	NULL

9	NULL
Levine	NULL
,	NULL
M.	NULL
and	NULL
J.L	NULL
.	NULL

Manley	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
405-408	NULL
.	NULL

10	NULL
Renkawitz	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

6	NULL
,	NULL
192-197	NULL
.	NULL

11	NULL
-	NULL
Rivier	NULL
,	NULL
D.H.	NULL
and	NULL
J.	NULL
Rine	NULL
(	NULL
1992	NULL
)	NULL
Current	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
286-292	NULL
.	NULL

12	NULL
Berg	NULL
,	NULL
PE	NULL
.	NULL

,	NULL
D.M	NULL
.	NULL

Williams	NULL
,	NULL
R.-L.	NULL
Qian	NULL
,	NULL
R.B	NULL
.	NULL

Cohen	NULL
,	NULL
S.-X	NULL
.	NULL

Cao	NULL
,	NULL
M.	NULL
Mittelman	NULL
and	NULL
A.N	NULL
.	NULL

Schechter	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
8833-8852	NULL
.	NULL

13	NULL
Cao	NULL
,	NULL
S.X	NULL
.	NULL

,	NULL
PD	NULL
.	NULL

Gutman	NULL
,	NULL
H.P.G	NULL
.	NULL

Dave	NULL
and	NULL
A.N	NULL
.	NULL

Schechter	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5306-5309	NULL
.	NULL

14	NULL
Elion	NULL
,	NULL
J.	NULL
,	NULL
RE	NULL
.	NULL

Berg	NULL
,	NULL
C.	NULL
Lapoumerouilie	NULL
,	NULL
G.	NULL
Trabuchet	NULL
,	NULL
M.	NULL
Mittelman	NULL
,	NULL
R.	NULL
Krishnamoorthy	NULL
,	NULL
A.N	NULL
.	NULL

Schechter	NULL
and	NULL
D.	NULL
Labie	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
787-792.	NULL
ti	NULL
B	NULL
uo	NULL
3672	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

18	NULL
15	NULL
16	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
Gumucio	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
H.	NULL
Heilstedt-Williamson	NULL
,	NULL
T.A	NULL
.	NULL

Gray	NULL
,	NULL
S.A.	NULL
Tarle	NULL
,	NULL
D.A	NULL
Shelton	NULL
,	NULL
D.A	NULL
.	NULL

Tagle	NULL
,	NULL
J.L	NULL
.	NULL

Slightom	NULL
,	NULL
M.	NULL
Goodman	NULL
and	NULL
FS	NULL
.	NULL

Collins	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4919-4929	NULL
.	NULL

Lewis	NULL
,	NULL
W.	NULL
,	NULL
J.-D.	NULL
Lee	NULL
and	NULL
J.B.	NULL
Dodgson	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
19	NULL
,	NULL
5321-5329	NULL
.	NULL

Lumelsky	NULL
,	NULL
NL	NULL
.	NULL

and	NULL
B.G	NULL
.	NULL

Forget	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3528-3536	NULL
.	NULL

MacLeod	NULL
,	NULL
K.	NULL
and	NULL
M.	NULL
Plumb	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4324-4332	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
G.J	NULL
.	NULL

Grindley	NULL
,	NULL
P.	NULL
Bushel	NULL
,	NULL
L.	NULL
Mendelson	NULL
and	NULL
M.	NULL
Allan	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1209-1216	NULL
.	NULL

Gomez-Cuadrado	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Rousseau	NULL
,	NULL
J.	NULL
Renaud	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1857-1866	NULL
.	NULL

Rousseau	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Renaud	NULL
and	NULL
A.	NULL
Ruiz-Carrillo	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
7495-7511	NULL
.	NULL

Youssoufian	NULL
,	NULL
H	NULL
and	NULL
HF	NULL
.	NULL

Lodish	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
98-104	NULL
.	NULL

Rahuel	NULL
,	NULL
C.	NULL
,	NULL
M.-A	NULL
.	NULL

Vinit	NULL
,	NULL
V.	NULL
Lemarchandel	NULL
,	NULL
J.-P.	NULL
Cartron	NULL
and	NULL
PH	NULL
.	NULL

Romeo	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
4095-4102	NULL
.	NULL

Schewe	NULL
,	NULL
T.	NULL
,	NULL
S.M	NULL
.	NULL

Rapoport	NULL
and	NULL
H.	NULL
Kuhn	NULL
(	NULL
1986	NULL
)	NULL
Enzymol	NULL
.	NULL

Related	NULL
Areas	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

58	NULL
,	NULL
192-271	NULL
.	NULL

Schewe	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Wiesner	NULL
and	NULL
S.M	NULL
.	NULL

Rapoport	NULL
(	NULL
1981	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

71	NULL
,	NULL
430-441	NULL
.	NULL

Sigal	NULL
,	NULL
E.	NULL
,	NULL
S.	NULL
Dicharry	NULL
,	NULL
E.	NULL
Highland	NULL
and	NULL
W.E	NULL
.	NULL

Finkbeiner	NULL
(	NULL
1992	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

Lung	NULL
Cell	NULL
.	NULL

Mol	NULL
.	NULL

Physiol	NULL
.	NULL

262	NULL
,	NULL
L392-L398	NULL
.	NULL

Sigal	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
Grunberger	NULL
,	NULL
J.R.	NULL
Cashman	NULL
,	NULL
C.S	NULL
.	NULL

Craik	NULL
,	NULL
G.H	NULL
.	NULL

Caughey	NULL
and	NULL
J.A	NULL
.	NULL

Nadel	NULL
(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

res	NULL
.	NULL

Commun	NULL
.	NULL

150	NULL
,	NULL
376-383	NULL
.	NULL

Sigal	NULL
,	NULL
E.	NULL
and	NULL
J.A	NULL
.	NULL

Nadel	NULL
(	NULL
1988	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Repir	NULL
.	NULL

Dis	NULL
.	NULL

138	NULL
,	NULL
$	NULL
35-	NULL
$	NULL
40	NULL
.	NULL

Thiele	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
J.	NULL
Fleming	NULL
,	NULL
K.	NULL
Kasturi	NULL
,	NULL
J.	NULL
O'Prey	NULL
,	NULL
E.	NULL
Black	NULL
,	NULL
J.	NULL
Chester	NULL
,	NULL
S.M	NULL
.	NULL

Rapoport	NULL
and	NULL
PR	NULL
.	NULL

Harrison	NULL
(	NULL
1987	NULL
)	NULL
Gene	NULL
57	NULL
,	NULL
111-119	NULL
.	NULL

Thiele	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
H.	NULL
Andree	NULL
,	NULL
M.	NULL
Hohne	NULL
and	NULL
S.M	NULL
.	NULL

Rapoport	NULL
(	NULL
1982	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

129	NULL
,	NULL
133-141	NULL
.	NULL

O'Prey	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Chester	NULL
,	NULL
B.J	NULL
.	NULL

Thiele	NULL
,	NULL
S.	NULL
Janetzski	NULL
,	NULL
S.	NULL
Prehn	NULL
,	NULL
Fleming	NULL
,	NULL
J.	NULL
and	NULL
PR	NULL
.	NULL

Harrison	NULL
(	NULL
1989	NULL
)	NULL
Gene	NULL
84	NULL
,	NULL
493-499	NULL
.	NULL

32	NULL
33	NULL
34	NULL
35	NULL
37	NULL
38	NULL
39	NULL
45	NULL
46	NULL
47	NULL
48	NULL
49	NULL
Kulesz-Martin	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Kilkenny	NULL
,	NULL
K.	NULL
A.	NULL
Holbrook	NULL
,	NULL
V.	NULL
Digernes	NULL
and	NULL
S.	NULL
H.	NULL
Yuspa	NULL
(	NULL
1983	NULL
)	NULL
Carcinogenesis	NULL
4	NULL
,	NULL
1367-1377	NULL
.	NULL

Kim	NULL
,	NULL
S.C.	NULL
and	NULL
W.	NULL
Szybaiski	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
71	NULL
,	NULL
1-8	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
and	NULL
A.	NULL
R.	NULL
Coulson	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74	NULL
,	NULL
5463-5467	NULL
.	NULL

Spandidos	NULL
,	NULL
D.	NULL
and	NULL
N.	NULL
Wilkie	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
310	NULL
,	NULL
469-474	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
B.	NULL
Luscher	NULL
and	NULL
R.	NULL
Tijan	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1557-1569	NULL
.	NULL

Flanagan	NULL
,	NULL
J.R.	NULL
,	NULL
K.G	NULL
.	NULL

Becker	NULL
,	NULL
D.L	NULL
.	NULL

Ennist	NULL
,	NULL
S.L	NULL
.	NULL

Gleason	NULL
,	NULL
PH	NULL
.	NULL

Driggers	NULL
,	NULL
B.Z	NULL
.	NULL

Levi	NULL
,	NULL
E.	NULL
Apella	NULL
and	NULL
K.	NULL
Ozato	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
38-44	NULL
.	NULL

Park	NULL
,	NULL
D.	NULL
and	NULL
ML	NULL
.	NULL

Atchison	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
9804-9808	NULL
.	NULL

Safrany	NULL
,	NULL
G.	NULL
and	NULL
RP	NULL
.	NULL

Perry	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
5559-5563	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Seto	NULL
,	NULL
L.S	NULL
.	NULL

Chang	NULL
and	NULL
T.	NULL
Shenk	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
377-388	NULL
.	NULL

Pierce	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
A.M.	NULL
Gifford	NULL
and	NULL
D.	NULL
Baltimore	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1431-1437	NULL
.	NULL

Winoto	NULL
,	NULL
A.	NULL
and	NULL
D.	NULL
Baltimore	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
649-655	NULL
.	NULL

Currie	NULL
,	NULL
R.A.	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
4239-4247	NULL
.	NULL

Gumucio	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
D.A	NULL
.	NULL

Shelton	NULL
,	NULL
W.J	NULL
.	NULL

Bailey	NULL
,	NULL
J.L	NULL
.	NULL

Stightom	NULL
and	NULL
M.	NULL
Goodman	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
6018-6022	NULL
.	NULL

Hariharan	NULL
,	NULL
N	NULL
,	NULL
D.E	NULL
.	NULL

Kelley	NULL
and	NULL
RP	NULL
.	NULL

Perry	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
9799-9803	NULL
.	NULL

Lee	NULL
,	NULL
J.-S.	NULL
,	NULL
K.M	NULL
.	NULL

Galvin	NULL
and	NULL
Y.	NULL
Shi	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
6145-6149	NULL
.	NULL

Riggs	NULL
,	NULL
K.J	NULL
.	NULL

,	NULL
K.T	NULL
.	NULL

Merrell	NULL
,	NULL
G.	NULL
Wilson	NULL
and	NULL
K.	NULL
Calame	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1765-1769	NULL
.	NULL

Baniahmad	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
C.	NULL
Steiner	NULL
and	NULL
R.	NULL
Renkawitz	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2297-2303	NULL
.	NULL

Ravid	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Doi	NULL
,	NULL
D.L	NULL
.	NULL

Beeler	NULL
,	NULL
D.J	NULL
.	NULL

Kuter	NULL
and	NULL
R.D	NULL
.	NULL

Rosenberg	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
6116-6127	NULL
.	NULL

